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Abstract 
Up to 80% of people diagnosed with multiple sclerosis (MS) experience Uhthoff’s 
phenomenon, which is characterised by a temporary worsening of neurological symptoms and a 
concomitant onset of fatigue during exercise and/or with exposure to a hot environment. In order 
to understand the best strategies to mitigate the onset of heat-related MS symptoms and 
associated fatigue, we need to closer examine the underlying physiological mechanisms 
responsible for this phenomenon. The purpose of the present thesis was to explore the potential 
thermo-physiological mechanisms responsible for Uhthoff’s phenomenon in heat-sensitive MS 
patients during rest and exercise in hot (up to 35°C) environments. Specifically, study 1 sought 
to determine whether resting core temperature and metabolic rate was elevated in people with 
relapsing-remitting MS and to assess whether an elevated resting core temperature was 
associated with subjective measures of physical, cognitive and psychosocial fatigue. Study 2 
sought to determine whether a contributing factor to heat intolerance in MS patients, was in part, 
a greater rise in core temperature by virtue of a blunted thermoregulatory response during 
exercise in warm (30°C) and hot (35°C) environments. This study measured deep core 
temperature, alongside sweating and skin blood flow responses in people with relapsing-
remitting MS, compared to healthy controls while cycling in climate-controlled chamber. 
Finally, study 3 assessed whether ingestion of cold-water during exercise in a warm environment 
could prolong exercise tolerance in heat-sensitive people with MS.
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Summary of Findings 
Study 1 was designed to reassess the previously reported notion that resting core 
temperature was elevated in people with relapsing-remitting MS, compared to healthy controls 
when using best practice, precision thermometry. Resting rectal (Tre) and esophageal (Teso) 
temperature, and metabolic rate were measured in 28 MS patients and 27 age-matched controls 
in a 25°C, 30% RH and 30°C, 30% RH environment. Tympanic membrane (Ttym) temperature 
was measured in a subset of 16 MS and 15 aged-matched controls in a 30°C, 30% RH 
environment only. A modified fatigue impact scale (MFIS) questionnaire was also used to assess 
psychological, physical and cognitive fatigue in the 30°C condition. Participants were asked to 
avoid exercise ~24 h prior to and caffeine consumption ~12 h prior to data collection. All data 
was collected between the hours of 0800 – 1300. Irrespective of ambient temperature, no 
between-group differences were observed for Tre (MS: 37.07±0.30°C; CON: 37.18±0.30°C; 
P=0.29), Teso (MS: 36.84±0.42°C; CON: 36.92±0.29°C; P=0.36) or resting VO2 (MS: 3.9±0.2 
ml·kg-1·min-1; CON: 3.9±0.2 ml·kg-1·min-1; P=0.67). Similarly, no between-group differences 
were observed for Ttym (MS: 36.52±0.38°C; CON: 36.61±0.33°C; P=0.55) in the 30°C condition. 
Resting Tre did not correlate with subjective measures of fatigue: physical: r= -0.11, P=0.67; 
cognitive: r= -0.14, P=0.60; and psychosocial: r=0.05, P=0.84. Findings from this study do not 
support those previously shown. Indeed, core temperature at rest when measured using precision 
thermometry widely recognised among the thermal physiology community as best-practice was 
not elevated in people with relapsing-remitting MS, compared to age-matched controls. 
Furthermore, there is no evidence that resting core temperature is associated with subjective 
measures of psychosocial, cognitive or physical fatigue. 
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Study 2 investigated the thermoregulatory response in 22 people with relapsing-remitting 
MS, while cycling at a fixed heat production (4 W·kg-1) for 40 minutes, in a warm (30°C, 30% 
RH) or hot (35°C, 30% RH) environment, compared to 22 age- and massed-matched healthy 
controls. Throughout the study, Tre and Tsk, as well as local sweat rate (LSR) and skin blood flow 
(SBF) were continuously measured. Irrespective of ambient temperature a delayed change in 
mean body temperature (ΔTb: 0.9 × Tre + 0.1 × Tsk [P=0.002]) and time at onset of sweating 
(P=0.002) on the forearm, but not the upper back (P=0.46) were observed in people with MS 
compared to healthy controls, despite a similar onset time of SBF (MS: 11±5 min; CON: 11±6 
min; P=0.89) and ΔTb for SBF onset (MS: 0.09±0.09°C; CON: 0.12±0.11°C; P=0.57). However, 
despite a blunted peripheral sudomotor response, the rise Tre (MS: 0.38±0.18°C; CON: 
0.37±0.18°C; P=0.67) after 40 minutes of exercise was similar between the MS and healthy 
control group in both the warm and hot environments. The change in Tsk during exercise was 
greater in the MS (1.50±0.72°C: P=0.02) compared to the CON group (1.00±0.67°C). In 
conclusion, while a mild sudomotor dysfunction is evident in people with MS, this 
thermoregulatory impairment is only enough to alter the superficial tissue temperature (i.e. skin) 
but not deep core temperature during exercise in warm and hot environments.  
Study 3 investigated the effect of cold (CLD; 1.5°C) compared to thermoneutral (NEU; 
37°C) water ingestion on exercise time to exhaustion in 10 people with relapsing-remitting MS 
compared to 10 aged-matched healthy controls (CON). All participants were required to cycle at 
40% of their VO2max for 60 minutes (or until volitional exhaustion) in a warm (30°C, 30% RH) 
environment while ingesting 3.2 ml·kg-1 of either cold or thermoneutral fluid after the 15th, 30th 
and 45th minute of exercise. Tre and Tsk alongside heart rate (HR) were measured throughout. All 
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CON participants were able to cycle for 60 minutes in both the CLD and NEU trials, while only 
3 out of 10 MS participants could complete 60 minutes of cycling in the NEU trial. The 
remaining 7 MS participants all cycled longer (P=0.006) in CLD (46.4±14.2 min) compared to 
NEU (32.7±11.5 min), despite similar elevations in absolute Tre (NEU: 37.32±0.34˚C; CLD: 
37.28±0.26˚C; P=0.44), change in Tre (NEU: 0.38±0.21˚C; CLD: 0.34±0.24˚C), absolute Tsk 
(NEU: 34.48±0.47˚C; CLD: 34.44±0.54˚C; P=0.82) and HR (NEU: 114±20 bpm CLD: 113±18 
bpm; P=0.38) for the same exercise volume. Taken together, these findings support the use of a 
practical cooling strategy to enhance exercise tolerance for people with MS. Results from this 
study also lend insight into the potential role of thermal perception in the modulation of exercise 
tolerance for heat-sensitive MS individuals. 
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1.0 INTRODUCTION 
Multiple sclerosis (MS) is a progressive auto-immune disease of the central nervous 
system (CNS) whereby demyelination of neurons results in lesions and atrophy of the brain and 
spinal cord. Approximately 25,000 Australians and 2.5 million people globally are living with 
MS [1]. Damage to myelin sheaths and neuronal connections compromises the functional 
integrity of the autonomic nervous system causing motor and sensory problems for all MS 
patients. Most commonly, people may experience fatigue [2], cognitive decline [3], loss of 
balance [4], blurred vision, sensory enhancement (tingling or burning) and/or loss (numbness) 
[5] and intolerance to the heat [6]. Indeed, up to 80% of people with MS experience heat 
intolerance, otherwise known as Uhthoff’s phenomenon which is characterised by a temporary 
worsening of symptoms and concomitant fatigue during exercise or exposure to hot 
environments [6]. An intolerance to the heat can be quite disabling for people with MS. 
Alongside a temporary worsening of symptoms, MS patients also report  an overall reduced 
capacity to perform household and/or work related tasks [2], an inability to self-care and the need 
for medical attention [2] when they ‘feel hot’. Despite the prevalence and impact of heat 
intolerance, the underlying physiological mechanisms are not well understood.  
Original research by Davis and Rasminsky [7,8] demonstrated the effect of changes in 
temperature on neuronal conduction in damaged peripheral nerves. It was hypothesised that as 
the temperature of a damaged nerve increased, the amplitude of an action potential decreased, at 
times resulting in complete conduction block. Subsequent cooling resulted in restoration of 
conduction and function of a nerve [8,9]. This research alluded to the idea that small rises in core 
temperature (0.2 to 0.5°C) for people with MS would reduce or block conduction in 
Introduction 
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demyelinated nerves, causing a temporary worsening of MS symptoms, which was reversible 
once core temperature returned to resting values. Notably, recent research has indicated that 
people with MS may be at an inherent disadvantage during exercise and/or heat exposure due to 
an elevated core temperature at rest which is associated with greater levels of subjective fatigue 
compared to healthy controls [10,11].  However, the robustness of this evidence seems 
questionable given that the authors deemed a resting core temperature of ~37.0°C to be elevated 
and more importantly, core temperature was measured using a standard off-the-shelf infrared ear 
thermometer in an uncontrolled environment. This topic will be addressed further in chapter 3. It 
is also possible that heat intolerance in people with MS is compounded by an impaired 
thermoregulatory capacity secondary to MS that results in greater rises in core temperature 
compared to healthy people. However, evidence supporting this notion is inconclusive, and no 
study has previously assessed the thermoregulatory capacity of people with MS during exercise 
in hot environments (i.e. >25°C), therefore the study detailed in chapter 4 will investigate 
thermoregulation during exercise in hot environments in people with MS. 
In attempt to avoid critical rises in body temperature and the subsequent worsening of 
symptoms, MS patients often report avoiding physical activity and/or going outdoors. However, 
a large body of research has also demonstrated the marked benefits of regular physical activity 
for this population as a disease modifying therapy [12] and for improving strength and 
cardiorespiratory health [13,14], sleep quality, sense of worth, and reductions in central and 
peripheral fatigue [15]. MS health organisations and professionals often provide loose guidelines 
as to how MS individuals should stay cool and avoid an onset of symptoms during hot weather 
and/or physical activity [16]. However, these guidelines typically suggest impractical or 
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expensive strategies such as staying indoors from 10 am – 3 pm, avoiding the outdoors 
completely during hot weather [17], or wearing heavy cooling vests [18]. Furthermore, strategies 
such as drinking water [19] are offered without any existing evidence regarding their efficacy for 
mitigating heat intolerance in people with MS. Most commonly, people with MS will use air-
conditioning to keep themselves cool [2,20]. Indeed, in Australia approximately 82% of people 
with MS use air-conditioning throughout the year and spend up to 14-times more (~$2 million 
annually) on air-conditioning compared to a healthy population. As such, it is evident that there 
is a need to identify both practical and economical evidence-based cooling strategies that can be 
used at home or in the work place. The study described in chapter 5 will explore the efficacy of 
cold fluid ingestion on exercise tolerance for heat-sensitive people with MS cycling in a hot 
environment.  
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1.2 OBJECTIVE AND HYPOTHESES 
The specific objective and hypotheses governing each of the original research chapters 
are as follows: 
Study 1: The aim of this study was to reassess the notion that resting core temperature is 
elevated in RRMS patients when measured using precision thermistors placed in the esophagus, 
rectum and tympanic membrane in a controlled, warm (30°C, 30% RH) and neutral (25C, 
30%RH) environment, compared to age-matched healthy controls. 2) To assess whether people 
with MS demonstrate a higher resting metabolic rate compared to healthy controls. 3) To identify 
whether resting rectal temperature is associated with subjective measures of fatigue in people 
with RRMS. 
Hypotheses: 1) People with RRMS will not demonstrate an elevated resting rectal, 
tympanic or esophageal temperature, compared to age-matched controls. 2) Resting metabolic 
rate will be similar between MS and control participants. 3) No association will be observed 
between rectal temperature and subjective measures of fatigue. 
Study 2:  To assess whether people with MS demonstrate impaired thermoregulatory 
responses, resulting in a greater rise in core temperature while exercising in a warm (30°C, 30% 
RH) and hot (35°C, 30% RH), compensable environment compared to mass- and age-matched 
control participants 
Hypothesis: Relative to control participants, people with MS will demonstrate larger 
rises in core temperature secondary to a blunted sweat response.   
Introduction 
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Study 3: To examine the effect of ingesting cold (1.5°C) compared to thermoneutral 
(37°C) water on exercise tolerance at a fixed low relative intensity (~40%VO2max), and the 
elevation in core temperature of heat-sensitive relapsing-remitting MS participants in a warm 
(30°C, 30% RH) environment 
Hypotheses: It is hypothesised that with thermoneutral water ingestion, exercise time 
will be shorter for MS compared to age- and fitness-matched control participants. It is also 
hypothesized that compared to thermoneutral water ingestion exercise time of MS participants 
will be extended with cold water ingestion due to a blunted rise in core temperature. 
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2.0 MULTIPLE SCLEROSIS 
Multiple sclerosis (MS) is an auto-immune, demyelinating disease of the central nervous 
system (CNS). Lesions and scars that reside on the brain and spinal cord result in progressive 
and chronic disability. Approximately 25,000 Australians and 2.5 million people worldwide are 
diagnosed with MS [1].  
The degree of neurologic impairment for people with MS is guided by the expanded 
disability severity scale (EDSS) which assesses the functional and sensory capacity of an 
individual [2]. Specifically, the EDSS assesses a person’s visual, pyramidal, cerebellar, sensory, 
ambulation, bowel and bladder dysfunction. The EDSS ranges from 1 to 10 (1: minimal 
disability, slight functional impairment, 5: disability can impair daily activity and the ability to 
walk, 7: disability impairs walking beyond 5 m and person shows dysfunction in four or more 
functional categories, 10: death). Parallel to disease severity are three classifications of MS 
(Figure 2.1) that refer to the time course and progression of the disease [3].  
Relapsing-remitting MS (RRMS): Approximately 80% of people with MS are diagnosed 
with RRMS. This classification describes an individual who experiences a definitive relapse (a 
worsening of neurologic symptoms) followed by a full, or close to full recovery. The length, 
severity and worsening of neurologic symptoms will differ between people [3]. 
Secondary-progressive MS (SPMS): People with SPMS all begin with RRMS. This 
classification describes a person who experiences definitive relapses however their disease 
course can progress in the absence of a relapse, in addition to a progressively worse baseline 
state between relapses [3].  
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Primary-progressive MS (PPMS): People with PPMS will experience a gradual yet 
progressive decline with their disease from diagnosis without the presence of a relapse. It is 
possible that these people will experience temporary improvements in their progression. Only 
~10% of people are diagnosed with PPMS [3].  
 
Figure 2.1. Classification and clinical course of MS. Figure taken (with permission) from Confavreux and Vukusic 
[4]. 
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It is important to note that a person’s EDSS score does not correlate with their disease 
classification. That is, a person diagnosed with RRMS can have the same EDSS as a person 
diagnosed with SPMS and PPMS. Albeit, due to the nature of PPMS and SPMS, a person within 
this disease classification is more likely to increase their EDSS score over time, compared to a 
person with RRMS. Within the scope of this PhD, only patients diagnosed with RRMS and an 
EDSS of 1-5 were recruited for our research. This was decided given the greater prevalence of 
people diagnosed with RRMS (>80%) and the likelihood of these individuals being more 
physically active. 
2.0.1 Uhthoff’s Phenomenon 
In 1890, Wilhelm Uhthoff  [5] was the first to demonstrate an intolerance to the heat for 
people with MS. After a bout of exercise, patients with MS developed amblyopia (lazy eye), 
changes in visual acuity, colour perception disturbances and leg weakness. On cessation of 
exercise, symptoms in all four patients slowly diminished. The term ‘Uhthoff’s phenomenon’ is 
now used to describe a transient worsening of signs and symptoms in MS patients during 
exercise or when exposed to hot environments.  
2.0.2 History of Heat Intolerance  
Between 1926 and 1938, MS was thought to be a bacterial disease. As such, several 
attempts were made to treat MS with hyperpyrexia [6-12] while observations of patient 
responses were recorded. Notably, the use of diathermy (inducing high body temperatures with 
electrical currents) over the spinal cord demonstrated symptom improvements in 10 out of 13 
patients in a study by Stephenson [6]. The same was observed by Neymann [10] who reported 
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symptom improvements in 11 out of 25 patients treated with electropyrexia (artificially induced 
fever) and endured elevated core temperatures of ~40.5°C for ~8 h.  However, despite some 
observed benefits of inducing hyperthermia, there were also numerous reports of a severe 
worsening of health and death during these studies [9,10]. In 1937, Simons [13] studied the 
effect of hot and cold ambient temperatures (heating and cooling strategies are unknown) on 
symptom worsening in MS patients through the use of questionnaires. Findings from this study 
demonstrated the heat decreased strength for 62% of patients, and 24% experienced worsening of 
their spasticity. The cold had little effect on symptom worsening and in some cases, cold 
exposure improved strength and spasticity in ~35% of patients.  
In 1950-1951[14,15] a series of studies were carried out to assess the effect of whole and 
partial body immersion in cold (18.8 – 22.7°C), warm (29.4- 36.6°C) and hot (40.5 – 48.8°C) 
water. These studies were seminal in identifying the precipitating factors that cause a worsening 
of symptoms for people with MS. In almost all instances, cold (18.8 – 22.7°C) and warm (29.4- 
36.6°C) water whole body immersion resulted in no change of neurological symptoms, only a 
few patients experienced discomfort with cold water immersion [14,15]. Yet, when patients were 
completely submerged in hot water, a reaction of local (arm and leg) and/or generalised 
weakness was noted, alongside dysarthria and changes in visual acuity. A worsening of 
neurologic symptoms was recorded in one patient after only 8 minutes of whole body immersion 
in hot water. Indeed, this patient, along with two others, lost complete motor control and were 
unable to prevent themselves from sliding completely into the bath when unsupported [15]. 
Notably, even when patients only submerged their arm in hot water, the same symptoms of 
generalised weakness, changes in visual acuity and dysarthria were recorded (Table 2.2). A 
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worsening of symptoms that occurred with only one arm immersed in hot water was reversed 
almost instantaneously when the arm was removed from the bath. What was more remarkable 
from these findings was the effect of arterial occlusion on symptom worsening when a single 
arm was placed in hot water. Indeed, occluding the submerged arm prevented any symptoms 
worsening, suggesting that warmed blood travelling back towards the heart and around the body 
may be responsible for a temporary worsening of symptoms in MS patients.  Following these 
investigations, for the next twenty years, [16-21] all research conducted confirmed a temporary 
worsening of symptoms during heat exposure. Specifically, Edmund and Fog [16] reported 
sensory disturbances, ataxia, dysarthria, changes in visual acuity and a reduction in tendon 
reflexes with hot water submersion. Furthermore, in 1959, Nelson [17] established a correlation 
between the rise in core (oral) temperature and the onset of symptoms in MS compared to other 
neurologically impaired patients. 
In 1971, Davis [22] investigated the potential link between an increase in ambient 
temperature and a decrease in axonal conductivity of a demyelinated nerve. Davis reported a 
decrease in the effective transmission of a signal (safety factor) of a demyelinated nerve 
compared to a myelinated nerve, leading to a reduction in the rate of depolarization and evoked 
potentials. It was noted that increases in nerve temperature as small at 0.5°C would cause a 
decrease in the amplitude of an action potential, and at some points, complete conduction block 
would occur. While important, one must cautiously interpret these findings given that 
observations were of damaged frog and guinea pig nerves, exposed outside of the animal’s body 
and were not in vivo experiments performed on MS patients.  
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Most research conducted after 1970 focused on the effects of heat on neuro-
ophthalmology for MS patients with optic neuritis [23-28]. Many patients with MS demonstrated 
abnormalities with visual acuity [24] alongside a decrease in visual evoked potentials [26] 
following acute bouts of heating. A decrease in somatosensory evoked potentials has also been 
reported in MS patients who exhibit signs of a fever [26] (core temperature > 39°C) and 
following whole body heating in a 60°C sauna [27]. It was also during this time that researchers 
reported the efficacy of a hot bath to diagnose MS [29]. However, this test was quickly dismissed 
when neurological signs that occurred due to immersion in hot water would persist for lengthy 
periods [30] and it became evident that symptoms that developed during hot water immersion did 
not return to baseline even after a patient was cooled [31]. 
Endeavouring to understand the cause for heat sensitivities in MS individuals, Post, et al 
[32] speculated that low somatostatin levels in the cerebral spinal fluid of MS patients during a 
relapse may be a trigger for heat-related symptoms. However in 1986, Emre [33] postulated that 
somatostatins could not be the cause of heat-induced symptoms given that exposure to hot 
environments do not cause a relapse, yet a temporary worsening of symptoms, and reduced 
somatostatin levels were only evident during a clinical relapse.  
In 1987, Honan [34] commented that when people with MS are exposed to cold 
environments, an increase in metabolic heat production induced via shivering caused a 
worsening of symptoms in 6 out of 6 patients.  Further case studies have been reported on MS 
patients who have died following four hours of sun exposure [35,36], and other patients who 
have experienced permanent worsening of their symptoms after obtaining third degree burns 
[37].  
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From the early 2000’s, most research investigating heat intolerance in people with MS 
examined the influence of core temperature on symptom worsening [38-41] or changes in 
cognition [41,42]. To the best of our knowledge, there is little research that has explored the 
influence of tissue temperature such as skin and muscle and afferent thermal sensation on heat-
related symptoms and associated fatigue. Indeed, the exact cause of symptom worsening during 
exercise and/or heat exposure for people with MS seems inconclusive. Although it is apparent 
that an increase in core temperature may play a role in symptom worsening, from the history of 
literature, it is also evident that people with MS can experience a transient worsening of 
symptoms even in the absence of increases in core temperature [17,34,43,14]
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   Observations 
Immersion Conditions Tested Performances 
Patients 
Time 
(min) 
Temperature 
(°C) 
Time until 
reaction to 
heat (min) 
Untested 
subjects report 
of weakness 
Decrease in grip 
strength 
Decrease in 
leg strength 
Decrease in 
Visual Acuity 
Decrease in 
Dysarthria 
MS Group 
MS 1 46 45.5 18: Left* Marked 0% 0% Moderate None Moderate 
MS 2 34 45.5 8: Right* Marked 50% 25% n/a None Marked 
MS 3 
a) 
b) 
 
44 
29 
 
44.4 
45 
 
20: Right* 
8: Left* 
 
Marked 
Marked 
 
66% 
50% 
 
75% 
60% 
 
Moderate 
n/a 
 
Moderate 
Moderate 
 
Marked 
Marked 
MS 4 
a) 
b) 
 
27 
50 
 
45.5 
44.4 
 
12:Left* 
10: Right* 
 
Marked 
Marked 
 
0% 
n/a 
 
60% 
n/a 
 
Moderate 
n/a 
 
Moderate 
Moderate 
 
Marked 
Moderate 
MS 5 42 44.4 5: Left* Moderate n/a n/a Marked Moderate Moderate 
Control Group 
CON 1 22 46.1 Right None 10% 0% n/a None None 
CON 2 27 46.1 Right None 0% 0% n/a None None 
CON 3 24 46.1 Right None 0% 0% n/a None None 
CON 4 21 46.1 Right None 0% 0% n/a None None 
CON 5 24 46.1 Right None 0% 0% n/a None None 
CON 6 21 46.1 Right None 0% 0% n/a None None 
* Indicates the arm that was immersed in hot water  n/a: Not applicable 
Table 2.1. Data from this table represents information recorded following single arm immersion in hot water for MS and control participants. Data represents the 
a) temperature of the water, b) time until symptom onset, c) subjective signs of weakness and d) other symptoms that were experienced by MS patients. This 
table was redrawn from Guthrie [15].
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2.1 HUMAN HEAT BALANCE  
At rest, the human body regulates an internal temperature of ~37.0 ± 0.5°C. Humans are 
continuously exposed to a changing environment, to which the body must respond to regulate 
internal temperature. There are six interactive parameters that influence the thermal environment 
to which humans respond. There are four environmental parameters; air temperature, radiant 
temperature, humidity and air velocity, and two personal parameters; activity and clothing 
properties [44]. An increase in metabolic rate produces considerable amounts of heat within the 
body that must be subsequently transferred to the surrounding environment to prevent 
overheating. When heat production (Hprod) exceeds heat loss, thermoregulatory effector 
responses will act to minimize the amount of heat that is stored within the body. The 
maintenance of heat balance between the body and the surrounding environment can be 
explained using the following equation:  
𝑀 − 𝑊 = 𝐸 + 𝑅 + 𝐶 + 𝐾 + 𝑆 
Where: M is metabolic energy expenditure; W is external work; E is evaporative heat loss 
from the skin surface; R is radiative heat loss; C is convective heat loss; K is conductive heat loss 
and S is the heat stored within the body.  
Collectively, R, C and K are considered dry heat exchange or sensible heat loss and E is 
evaporative heat exchange or insensible heat loss. The interaction between ambient and radiative 
temperature, humidity and air velocity, alongside metabolic heat production and clothing 
properties will, in part, influence heat loss from the body to the surrounding environment [44]. 
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Indeed, when considering heat balance at rest, in neutral environments, dry heat transfer will 
adequately maintain a relatively stable body temperature [44]. However, sensible heat loss will 
become progressively diminished as ambient temperature becomes closer to skin temperature, 
thus leading to a greater reliance on skin surface evaporation for the maintenance of heat balance 
[45].  
Radiative heat transfer (R) is the exchange of heat via electromagnetic energy between the 
skin and physical objects emitting/absorbing radiation within the surrounding environment. The 
emissivity of an object, alongside the surface area and angle of exposure to a radiative source and 
the temperature difference between the skin and a radiative source, all determine R [44].  Indoors, 
mean radiant temperature is equivalent to air temperature, permitting there are no surrounding 
objects that emit radiative heat. The sun is the primary source of radiative heat outdoors.  
However the effect of solar radiation on heat exchange depends upon the time of day, season, and 
cloud coverage [44].  
Convective heat transfer (C) from the skin surface is directly dependent upon the 
temperature gradient between ambient (Ta) and skin temperature (Tsk) and body surface area. 
When air velocity is greater than ~0.2 m/s [46] forced air flow predominates, in contrast to air 
velocities below 0.2 m/s where self-generated airflow will primarily contribute to C. It follows 
that when Ta is lower than Tsk, there will be heat loss to the surrounding environment, but when 
Ta exceeds Tsk, there will be heat gained from the environment. Furthermore, convective heat 
transfer may be influenced by clothing worn on an individual, however this will also depend 
upon posture and the insulation properties of the clothes worn [47].  
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Conductive (K) heat transfer occurs when the skin is in contact with another object. The 
rate of K is determined by the conductivity of an object, the total surface area in contact, the time 
spent in contact and the temperature gradient between an object and the skin surface [46,44]. 
Typically, K is negligible unless there is direct contact with an object, such as laying in a cold or 
hot bath [48], being in contact with ice blocks [25] or water perfused suits [49]. However, 
conductive heat exchange between the skin and the environment, particularly during exercise 
(e.g. when running and only the feet are in contact with the ground) is minimal in humans.  
The primary avenue of heat loss during exercise in the heat is evaporation of sweat 
secreted onto the skin surface (Esk)  [45,50]. The rate of Esk is determined by the partial pressure 
gradient of water vapour between the skin surface and ambient air (humidity). Importantly, it is 
the absolute, not relative humidity (RH) that determines the amount of sweat that will vaporise 
[51,52]. Approximately 2426 J of latent heat energy are required to vaporise 1 g of sweat [53]. 
Evaporative heat loss is determined using the following equation from Gagge  [54]. 
𝐸𝑠𝑘 = ℎ𝑒 ∙ 𝜔 ∙ (𝑃
𝑠𝑘 − 𝑃𝑎) 
Where Esk is evaporative heat loss; he is the evaporative heat transfer coefficient; ω is the 
fraction of the skin surface covered in sweat (skin wettedness); Psk - Pa is the difference in the 
partial pressure of water vapour between the skin and ambient air.  
In fixed environmental conditions, the theoretical maximum potential for evaporative 
heat loss (Emax) is the evaporative heat loss limit from a completely wet skin surface (i.e. a ω = 1) 
[53]. Submaximal rates of Esk relative to Emax can be described using the concept of skin 
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wettedness, where the ratio of Esk and Emax is the fraction of the skin surface that is covered in 
sweat that would result in Esk for a given environment [53]. The amount of skin wettedness 
required (ωreq) for heat balance represents the theoretical portion of skin surface that must be 
covered in sweat to achieve Ereq and is calculated as the ratio between Ereq and Emax. The amount 
of evaporation required (Ereq) to maintain heat balance is determined by metabolic Hprod (M-W) 
and environmental (Ta) parameters. At rest or during exercise, the rate of whole body sweating is 
largely dependent upon absolute Ereq, Ta and Tsk and heat production [55,56]. 
Attaining a ω of 1.00 is only possible in heat acclimated individuals [50] otherwise, it is 
likely without heat acclimation, a person may attain a ω of 0.85. ω is also related to sweating 
efficiency (the percentage of sweat that evaporates and contributes to heat loss) as such; any 
sweat secreted onto the skin surface that drips off the body will not provide any additional 
evaporative cooling. At a ω of 1.00, sweating efficiency will be ~50% [57], however a decrease 
is efficiency can occur at a critical ω of 0.5 to 0.7 for nude individuals and 0.2 when clothed 
[57]. 
When dry heat loss is not sufficient to offset an increase in heat production either during 
exercise, or passive heat exposure, then evaporative heat loss is required. An increase in air flow 
across the skin surface will also increase Emax, which means that the skin wettedness required for 
heat balance goes down and sweating efficiency improves (only if there are decrements in 
sweating efficiency in the first place). This may be particularly beneficial in hot and humid 
environments where an increase of  air velocity that crosses the skin surface will enhance 
evaporative heat loss [57].  
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To maintain zero heat storage (S), heat produced and transferred within the body must be 
equalled by heat loss (E + R + C + K) to the surrounding environment. During exercise, Hprod is 
determined by metabolic energy expenditure (M) and the portion of that heat which is used to 
create mechanical work (W; in watts). Hprod will also depend on the mechanical efficiency and 
economy of an individual [58,59] which is defined as the portion of metabolic energy 
expenditure that is converted to external work and is expressed as a percentage. The rate of M is 
governed by the absolute rate of oxygen consumption (VO2) and the proportion of oxygen that is 
used to catabolize carbohydrates and fats. M can be calculated using the following equation.  
               M = VO2 · 
((
𝑅𝐸𝑅−0.7
0.3
).𝐸𝑐) + ((
1−𝑅𝐸𝑅
0.3
).𝐸𝑓)
60
 · 1000 [W]  
Where: VO2 is the rate of oxygen consumption (Lmin-1); RER is the respiratory 
exchange ratio defined by the ratio of carbon dioxide produced and oxygen used during 
metabolism; Ec and Ef are the energetic equivalents of carbohydrate (21.13 kJL-1 of O2) and fat 
(19.62 kJL-1 of O2) respectively.  
At rest, metabolic heat production is ~100 W.  This Hprod may also depend upon body 
composition [60], ambient conditions [61], fever [62], and circadian rhythm [63]. Diurnal 
changes in Hprod and loss due to circadian rhythms elicit changes in core temperature by up to 
1°C over a 24 h sleep-wake cycle. However under varying conditions [64] small volumes of 
sympathetic outflow to the skin vasculature allow for changes in blood flow to adequately 
control S [65]. This is particularly so in thermoneutral environments where thermoregulatory 
responses such as sweating or shivering are not necessary to regulate S [66].  
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During active or passive heating, changes in Tcore are the result of a cumulative imbalance 
between Hprod and heat loss to the environment [67]. However, individual thermoregulatory 
responses and the subsequent rise in core temperature are highly variable [59]. To assess 
population differences in thermoregulation, many researchers employ a fixed percent of maximal 
oxygen capacity (%VO2max) exercise protocol [68]. These protocols are used as it is assumed that 
working at a fixed % of VO2max yields a similar rise in core temperature between groups, 
irrespective of maximal aerobic capacity [69]. However, when considering the heat balance 
equation, a group working at a greater %VO2max would undoubtedly produce greater amounts of 
metabolic heat and therefore would require a greater amount of evaporation to maintain heat 
balance. This was recently demonstrated by Jay et al [70]  who suggested that aerobic fitness 
should not independently alter the rise in core temperature during exercise. Indeed, when cycling 
at a fixed %VO2max, fitter individuals (~60 ml·kg
-1·min-1) demonstrated a greater rise in rectal 
temperature (ΔTre: 1.43°C) compared to less fit (~40 ml·kg-1·min-1) mass- and BSA- matched 
individuals (ΔTre; 0.89°C), however when cycling at a fixed heat production relative to total 
body mass, which represents the internal heat sink of an individual (W·kg-1), irrespective of the 
concomitant %VO2max, the rise in Tre was similar between groups. Smoljanic et al [58] also 
demonstrated thermoregulatory responses were not altered by aerobic fitness for individuals 
running on a treadmill. Indeed, Smoljanic’s research highlighted that people with a low running 
economy will demonstrate greater changes in Tcore at a fixed running speed compared to highly 
economical runners, however when running speed was fixed to elicit a heat production relative to 
body mass, the rise in core temperature was similar between groups, irrespective of aerobic 
capacity.   
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More recently, work by Cramer and Jay postulated that in order to eliminate any 
systematic differences in the exercise-induced rise in Tcore due to biophysical characteristics, 
researchers should prescribe exercise at an intensity that will elicit a fixed metabolic heat 
production per unit of total body mass (W·kg-1) irrespective of relative intensity [67,70,55,59]. 
Indeed, large differences in body mass independently alter the rise in Tcore when exercising at an 
absolute work load [67]. This is explained by an inverse relationship between the change in body 
heat content and the subsequent rise in Tcore with body mass [71]. As such, larger individuals are 
likely to have a smaller rise in Tcore at a fixed absolute heat production compared to a smaller 
individual due to the variability in body mass [71,67]. Body surface area will also influence heat 
exchange with the environment. Rates of evaporative, convective and radiative heat exchange 
will be greater for people who have a higher BSA [59]. It is important to consider differences in 
body mass and surface area, particularly when comparing between group thermoregulatory 
responses to passive and or active heating. Specifically, when assessing thermoregulation 
between people with MS and healthy controls at rest and during exercise, controlling for 
morphological characteristics means that dry heat exchange and the Ereq for heat balance should 
be similar between groups. As such, any differences in Tcore and Tsk or sweat rates would be due 
to the disease itself [72].  
2.1.1 Core Temperature 
Core temperature may be regarded as temperature of the brain, deep tissues and blood 
[73]. It is difficult to obtain a direct measure of core temperature from a single point within the 
body. As such, there are multiple sites that researchers may use to measure and record Tcore. The 
rectum, esophagus and tympanic membrane are the preferred measurement sites for thermal 
 Literature Review 
36 
 
 
physiological studies [74-78] and are the three core temperature sites that will be reported within 
this thesis. Rectal temperature (Tre) at rest, is generally higher than esophageal (Teso) [79] and 
tympanic membrane temperature (Ttym) [73], which is likely due to a lower rate of blood flow to 
the splanchnic area, which in turn decreases the amount of internal conductive and/or convective 
heat exchange of this tissue region [73]. Blood supply to the rectal tissues is received from the 
superior rectal artery, which stems from the aortic abdominal artery from the splanchnic area 
[80]. In some situations, such as assessing core temperature at rest, a low thermal inertia in the 
rectum may be advantageous as this measurement remains relatively stable under mildly varying 
environmental conditions [73]. Indeed, because of its validity and accuracy, Tre is commonly 
measured in clinical [81,77] and athletic [82,74] settings for diagnosing fever and heat stroke 
respectively and in laboratory setting as an indication of deep tissue temperature at rest or during 
exercise in hot and cold environments [83,61,84]. 
The distal esophagus is bound by the heart and pulmonary arteries, and because it has a 
relatively low heat capacity, Teso is finely regulated by the convective heat transfer of the blood 
from surrounding tissues [79,73].  Esophageal temperature is highly sensitive to changes in 
central blood temperature and whole-body heat storage [75] which promote the reliability of this 
measurement, specifically when assessing thermoeffector responses to heat exposure [85-87] and 
for detecting hypo- and hyper-thermia in intraoperative and postoperative adult patients 
[77,88,89]. Esophageal temperature may prove difficult to measure within some populations due 
to the discomfort it can cause. Furthermore, the placement of a sensor within the esophagus 
means this measurement site may not be ideal for assessing cooling interventions, such as cold 
fluid ingestion.   
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Blood to the tympanic membrane is supplied from the maxillary and posterior auricular 
artery, as such, Ttym can provide a valid indication of blood temperature entering the 
hypothalamus [44,90]. There are many controversies surrounding the use of the tympanic 
membrane as a measure of core temperature given the accuracy of this measure heavily depends 
upon the placement of a temperature sensor relative to the tympanic membrane, which can be 
influenced by the curvature of the ear canal, build-up of cerumen within the ear [91], and the 
temperature of the environments and skin surrounding the neck and ear [92]. The method of 
measuring Ttym may also heavily influence the accuracy and validity of this measure. Indeed, 
many clinicians may use an infrared ear thermometer to measure Ttym as it provides a quick and 
practical alternative of measuring core temperature. This may be problematic due to the 
placement of an infrared thermometer in the ear, which means a measure may give a better 
indication of auditory canal temperature, which is heavily influenced by Tsk of the face and head 
[93,94]. Nonetheless, if measured correctly [90], Ttym  will provide an accurate measure of core 
temperature and may be useful for assessing changes in core temperature [95,96] or core 
temperature at rest [96]. 
2.1.2 Skin Temperature 
Skin temperature is considered the ‘shell’ of the body and is critical with respect to the 
heat balance parameters mentioned in section 2.1. Skin temperature is also important in 
determining transcutaneous heat flux [97] and mean body temperature [0.9 x Tcore + 0.1 x Tsk 
(Tb)] which is used as a feedback signal for effector responses alongside precipitating factors 
such as thermal sensation and comfort [98]. Skin temperature is not uniform across the body and 
is therefore expressed as a weighted average. For example, Ramanathan [99] developed an 
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equation for mean skin temperature using four sites across the body (chest 30%, shoulder 30%, 
thigh 20%, and calf 20%), while Nadel [100] developed a novel approach in determining mean 
Tsk by basing regional weightings on the thermal sensitivity of each location ( face 21%, cheat 
21%, back 21%, abdomen 17%, thigh 15%, calf 8%, upper arm 12%, forearm 6%). The number 
of skin sites needed to determine Tsk is influenced by ambient temperature and the potential 
variability of skin temperature across the body. As such, in warm environments four skin 
temperature sites will be sufficient, in thermoneutral conditions, 8-12 sites and in cold 
environments, 8-12 sites [101].  
2.2 AUTONOMIC THERMOREGULATION 
2.2.1 Peripheral and Central Control of Temperature Regulation 
Cold and warm temperature sensitive neurons (thermoreceptors) located both centrally 
(brain, spinal cord and viscera) and peripherally (skin and muscles) within the body, are 
responsible for temperature control of the body [102]. Thermoreceptors provide afferent 
information regarding changes to the body’s thermal status, which trigger effector responses that 
activate the autonomic processes of temperature control [102-104]. The preoptic area of the 
hypothalamus acts as the control centre control for heat production (posterior preoptic area) and 
heat loss (anterior preoptic area) mechanisms [66]. Furthermore, thermoreceptors embedded 
within the epidermis and dermis layers of the skin provide afferent signaling for autonomic, as 
well as behavioural thermoregulation [103].  
At rest, or during exercise, a combination of afferent signals from both peripheral and 
central thermoreceptors serve to maintain Tcore and are responsible for efferent outputs such as 
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the onset and thermosensitivity of sweating [66,105] and vasodilation [106,107].  Typically, the 
rise in Tcore dictates the onset of an efferent response and peripheral input (Tsk) governs the slope 
(sensitivity) of that efferent response [108,109]. The relative contributions of central and 
peripheral input for heat loss are 9:1 [109,97,110] in hot/warm conditions, meaning that a 1°C 
change in Tcore will elicit and efferent response 9 times greater than a 1°C change in Tsk. 
However the onset and slope of efferent output may be altered by physical training [111], heat 
acclimation [112], baroreceptor unloading [113] and dehydration [86].  
In absence of a rise in core temperature, deviations in Tsk can contribute to the regulation 
of efferent responses [97]. For example when sitting in a hot room or at the beginning or 
exercise, there is a is an initiation of sweating due to a rise in Tsk in absence of a change in Tcore 
[100,105]. However, even without a detectable change in Tcore and Tsk, Van Beaumont [114] 
observed sweating within 1.5 to 2 seconds of the onset of exercise, which was also observed by 
Gisolfi [115] in 1970. It was hypothesised that a  non-thermal neural activation of sweating 
predominates at the beginning of exercise, however as work or heat exposure continues, 
sweating will be controlled by thermal factors such as mean body temperature [116].  
Traditionally, it follows that thermal homeostasis is maintained around a single set core 
temperature point, and minor deviations away from this set point will elicit an efferent response 
[117]. However it is more likely that peripheral and central thermoreceptors provide integrated 
feedback regarding body heat storage and activate an efferent response relative to the rate of heat 
storage [66,64]. Lastly, it is possible that afferent and/or efferent signalling is compromised for 
those individuals who demonstrate damage within the central nervous system. Indeed, for people 
with MS, it is possible that slowing or complete block of neuronal signals due to an increase in 
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body temperature will affect afferent input and/or efferent output, thereby compromising one’s 
ability to regulate body temperature [22,118]. This topic will be discussed later within the thesis.  
2.2.3 Skin Blood flow 
Regulation of cutaneous circulation is essential to sustain heat balance at rest and during 
exposure to hot and cold environments. Skin blood flow is controlled by sympathetic adrenergic 
vasoconstrictor and sympathetic vasodilator nerves which innervate nonglabrous skin. This is in 
comparison to glabrous skin, defined as skin of the palms, soles and lips which is only innervated 
by sympathetic vasoconstrictor nerves [119-122]. In brief, sympathetic vasoconstrictor nerves 
release norepinephrine to interact with cutaneous arterioles and alter the dilation of blood 
vessels. At rest, in thermoneutral environments, the vasoconstrictor system is active [122,106] 
and small amounts of sympathetic outflow to the skin vasculature allow for changes in blood 
flow to adequately control body temperature [65]. Cutaneous blood flows at ~250 ml·min-1 
contributing to approximately 100 W of heat loss, equal to metabolic heat production at rest 
[122].  
During exercise, increases in Tcore and Tsk elicit a central response to activate 
vasodilation. This active vasodilation is responsible for 80-90% of blood that is redirected to the 
skin surface [119]. Redistribution of blood allows for convective heat transfer from the core to 
skeletal muscles and then Tsk for heat exchange to surrounding environment [123]. The transfer 
of heat from the body’s core to the skin is dependent upon the Tcore to Tsk gradient and the rate of 
skin blood flow which is dependent upon vascular resistance [106]. Independently of changes in 
Tcore, the degree of active vasodilation depends on the temperature of the skin [119,123,124]. 
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Indeed, when Tsk is cool (~30°C) the active vasodilator response to rises in Tcore will be 
supressed [124]. On the other hand, when Tsk is high (~37°C) the cutaneous vasculature should 
be completely dilated.  
During exercise, with an increase in metabolic heat production, there becomes a 
competitive demand between blood that is directed towards the cutaneous vasculature and 
oxygen supply to the working muscles. Cutaneous sympathetic vasoconstrictor and vasodilator  
output contribute to baroreflex control of blood pressure, which is particularly important during 
prolonged exercise and/or heat stress [122]. Vasoconstriction of other areas such as the 
splanchnic region, is paralleled with increases in cardiac output, allowing for adequate 
redistribution of blood to the vasculature of the skin and working muscles [122].  However, with 
the need for adequate circulation of blood around the body, it is possible that cardiac demands 
will lead to orthostatic intolerance and syncope particularly in hot environments [125].  
A change in vasomotor tone can also occur via local heating and cooling [106, 122]. 
Indeed, an initial spike in skin blood flow from a warm local stimulus is driven by neural 
mechanisms, namely C-afferent fibers that stimulate neuro-transmitters to act upon the smooth 
muscle [106, 122]. Following this initial spike, there is a complex integration of both neural and 
non-neural factors that control skin blood flow with local heating [106]. An in-depth overview of 
the chemical messengers that contribute to vasodilation of local heating will not be discussed 
within this thesis, however this information can be found in a Comprehensive Physiology review 
by Johnson et al [106].   
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2.2.3 Sweating 
Humans have two types of sweat glands, apocrine and eccrine. Apocrine sweat glands are 
primarily located on the palmar, plantar, axilla, forehead and pubic regions of the body [126]. 
Sweat produce from apocrine glands is primarily activated by a psychological stimulus. Eccrine 
sweat glands reside across the entire body and are primarily responsible for producing sweat for 
body temperature regulation during exercise and/or exposure to hot environments [127]. The 
distribution, density and secretory activity of eccrine sweat glands across the body varies 
considerably [128,129].  
Sweating is controlled by the integration of central and peripheral input. An input 
stimulus sends efferent information down cholinergic sympathetic neurons to the secretory cells 
of eccrine sweat glands. Once this process occurs, acetylcholine is released to stimulate sweating 
[127]. Within the sweat gland, a hypotonic solution is formed via active reabsorption of sodium 
and chloride which eventually reaches the skin surface [130].  
The initial onset of sweating is due to the activation of sweat glands, and the rate of sweat 
production is the result of increased sweat output per active gland [131]. Early reports by 
Benzinger [132] demonstrated an increased sweat rate during steady state exercise was almost 
proportional to increases in Ttym and Tsk. These findings were later confirmed by Nielson et al 
[133] and Nadel [108] who demonstrated a correlation between a rise in Tb and the onset of 
sweating. While it is evident that Tb regulates sweating via central mechanisms, research has also 
demonstrated the influence of peripheral and visceral thermoreceptors to independently modulate 
local and/or whole-body sweating rate independently of Tcore [134-136]. Bothorel [134] 
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demonstrated a reduction in sweat rate across the entire body when Tsk on the right, but not the 
left thigh was decreased. Furthermore, Van Beaumont [136] reported differences in sweat gland 
output on the forearm with different local Tsk, but a constant Tre. Lastly, Morris et al [83] 
demonstrated the influence of thermoreceptors that reside in the gut to increase or decrease sweat 
output with 1.5°C and 50.0°C water ingestion, independently of any changes in Tcore or Tsk. In all 
instances, deviations in sweating rate occurred almost immediately following the application of a 
cold or hot stimulus. It therefore appears that activation of local thermoreceptors considerably 
contributes to thermoregulatory control independently of core and skin temperature.   
From a thermoregulatory perspective, sweat production, and the subsequent evaporation 
of sweat must be adequate to compensate for Hprod during exercise. With diseases such as MS, 
sweat production during exercise may be blunted due to autonomic dysfunction of the sudomotor 
system, potentially eliciting a greater rise in core temperature. This topic will be discussed in the 
next section.  
2.3 THERMOREGULATION IN MS 
2.3.1 Thermoregulation During Rest in Normothermic Environments 
At rest, Tcore remains around ~37.0°C however, throughout a 24 h sleep-wake cycle, Tcore 
can change by up ±0.5°C [63] with the highest Tcore occurring in the afternoon and the lowest 
Tcore occurring in the morning.  In people with MS, some studies have observed changes in visual 
acuity associated with the circadian phase changes in body temperature [19,137]. Namerow [19], 
identified a worsening of visual acuity in an MS patient with optic neuritis in the afternoon (Oral 
temperature: ~37.0°C) compared to the morning (oral temperature: ~36.0°C) which was also 
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observed by Romani [137]. Research has also demonstrated greater levels of subjective fatigue in 
the afternoon and evening compared to the morning in MS patients [138,139], however no direct 
relationship between fatigue and circadian rhythm has been established.  
More recently, it has been suggested that individuals with relapsing-remitting (RRMS) 
but not secondary-progressive MS (SPMS), present with an elevated core temperature (~37.0°C) 
at rest (Figure 2.2), compared to healthy controls (36.8°C) and this elevated core temperature is 
associated with greater levels of subjective fatigue [140,141]. Irrespective of changes in Tcore due 
to circadian rhythm, the mechanisms explaining an elevated Tcore at rest in MS patients, 
particularly in normothermic environments, remain unclear. The authors of this research 
postulated that an elevated Tcore in RRMS patients compared to patients with progressive forms 
of the disease (secondary- and primary-progressive), was attributed to inflammation within the 
CNS, akin to inflammatory induced fever [142] in healthy populations. Problematically if MS 
related inflammation was to elevate Tcore, akin to the mechanisms of a fever, clinical 
manifestations such as an increased basal metabolic rate and cutaneous vasoconstriction [62,143] 
would also be evident. Nonetheless, there have been no reports of resting vasomotor dysfunction 
[144] or abnormal basal metabolic rates [145] in association with a core temperature of ~37.0°C 
in MS patients. Moreover, the robustness of these findings are questionable considering the 
authors deemed a resting Tcore of ~37.0°C to be “elevated”, and furthermore, core temperature 
was recorded using a standard, off-the-shelf infrared ear thermometer in an uncontrolled 
environment at apparently random times during the day [140,141]. As such, it is unclear whether 
Tcore is truly elevated in RRMS patients and whether subjective fatigue is associated with resting 
Tcore. 
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Figure 2.2 Body temperatures in healthy persons, patients with RRMS, and patients with SPMS. Lines indicate the 
mean body temperature for healthy controls (dotted), patients with RRMS (solid), and patients with SPMS (dashed). 
Figure taken (with permission) from Sumowski et al [140].  
2.3.1 Thermoregulation During Active and Passive Heating 
To date, few studies have assessed the integration of central and peripheral control of 
temperature regulation in people with MS during active and/or passive heating. In 1968, 
Noronha [146] reported qualitative evidence of sudomotor dysfunction in people with MS during 
a bout of passive heating. Whole body sweat output was assessed using quinizarin powder, a 
grey powder that covers the body and turns black when in contact with sweat. Regional 
differences in sweat production were observed in 25 out of 60 MS patients. Using the same 
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quinizarin powder test, Vas [147] in 1969 reported abnormal, or an absence of sweating in 13 out 
of 37 men and Cartlidge [148] in 1972, who reported abnormal sweating in 20 out of 50 males 
who were passively heated. All these studies [146-148] commented that the degree of sweating 
abnormalities/absence was correlated with a greater disease severity. However, during bouts of 
passive heating, no studies reported symptom worsening or abnormal rises in core temperature.  
Further work by Noronha [146] investigated the use of a cholinergic agonist agent on 
sweat output for MS patients who previously demonstrated abnormal/absence sweating. There 
was an increase in sweat output for patients who showed abnormal sweating but not in those 
patients who had a complete absence of sweating. Similarly, Davis et al [149] concluded that a 
blunted sweating response observed in MS patients was the result of impaired sweat gland 
activation and not sweat output of activated glands. Furthermore, Allen et al [144] investigated 
the sudomotor response to passive heating in a 48°C water perfused suit and reported that the 
average sweat rate in people with MS was 0.17 mgcm-2min-1 lower compared to healthy 
controls for the same rise in core temperature (0.8°C).  
Despite a blunted sudomotor response, people with MS demonstrate normal vasomotor 
responses to passive heating. Cartlidge [148] reported normal vasomotor responses in MS 
patients despite a blunted sudomotor response to passive heating. Allen et al [144] also observed 
that a blunted sudomotor response to whole body passive heating was not paralleled with blunted 
vasomotor activity. Anderson et al [150] reported both central and peripheral mediated 
sympathetic vasomotor reflex responses were normal in MS patients compared to non-MS 
patients, despite observations of sudomotor dysfunction. Anderson and Cartlidge both postulated 
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that sudomotor and vasomotor pathways must be controlled somewhat separately for these 
differences to occur.  
Problematically, research investigating sudomotor function in people with MS has yet to 
identify whether a blunted sweat response is large enough to elicit greater rises in core 
temperature, specifically in a non-encapsulated environment [139,140]. Furthermore, it is 
currently unknown whether heat sensitivities occur by virtue of a blunted sweat response that 
cause people with MS to get hotter during exercise and/or exposure to hot environments. It is 
well established that exercise is an integral component of symptom management and well-being 
for people with MS [151], however, many people with MS do not partake in regular physical 
activity due to their intolerance to the heat. As such, it is evident that research is needed to 
identify whether autonomic dysfunction impairs central and peripheral control on temperature 
regulation to the point that it is contributing factor to the development of Uhthoff’s phenomenon.  
2.4 COOLING STRATEGIES IN MS 
In 1959, Watson [152] demonstrated the effects of cold air or water immersion on 
symptom improvement in people with MS. Even without an increase in body temperature, 8 
patients demonstrated improvements with vision, spasticity and weakness with decreases in body 
temperature of 0.34 to 1.2°C. Notably, cold water immersion had no effect on symptom 
improvement for those patients who demonstrated no decrease in body temperature [152]. 
Capello [153] studied the effects of a ‘cooling program’ on symptom improvement for MS 
patients. The program involved 2 × 45-minute bouts of cooling (temperature unknown), every 
day for one month. MS patients improved their disability status (EDSS) following a month of 
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persistent cooling, and psychological benefits following one day’s worth of cooling was also 
noted. The authors hypothesised that the benefits of cooling arose from an improvement in the 
safety factor (effective transmission of a signal) of neural conductivity and increases in the 
amplitude of evoked potentials. This idea was further investigated by Robinson et al [154] who 
reported that cooling did not change or improve somatosensory evoked potential in MS 
compared to healthy control participants following a bout of cooling using an ice vest. In 2000, 
White el at [48] assessed the effects of 30 min lower limb cooling (16°C) on fatigue and gait 
following 40 minutes of exercise. Immediately following exercise, fatigue was lower and time to 
walk 25 ft was reduced compared to an exercise bout where patients were not pre-cooled. 
However, the transient effects of cooling were observed 30 minutes following cessation of 
exercise when both fatigue and gait had returned to baseline values in both the pre-cooling and 
no-cooling trials.  
Research investigating the effects of cooling on symptom improvement in MS patients 
has been done so in the absence of prior increases in body temperature [18,152,153,155,156]. 
Beenakker [38] investigated the effects of a power charged head-neck cooling vest on self-
reported fatigue, postural sway and muscle strength. Following three hours of cooling, 
improvements in subjective fatigue, postural sway and muscle strength without a reduction in 
tympanic membrane temperature were reported. However, the clinical significance of these 
results may be somewhat overshadowed given it took 3 h to achieve any noticeable difference in 
the measures reported. Grahn et al [157] in 2007 demonstrated the efficacy of cooling one hand 
in a 18-22°C glove on exercise time in heat-sensitive MS patients.  Hand cooling elicit a ~30% 
increase in time spent walking on a treadmill compared to no hand cooling. No measure of Tcore 
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or Tsk were reported, however the authors suggested that heat loss via conduction allowed the 
body to reduce Tcore and subsequently improve performance. In this study, participants were 
walking on the treadmill at a speed of 0.8 to 4.8 km·h-1 at a slope ranging between 0 – 8 %. 
Because Tcore or Tsk was not measured, it is unclear whether conductive heat loss in the cooled 
hand was sufficient to offset heat production during exercise for the MS participants, and it is 
likely that a local vasoconstriction would have minimized net conductive heat loss over a 
relatively small absolute surface area. Meyer-Heim [156] also reported an improvement in 
subjective fatigue and a decreased time to walk 25 ft. (by 4 s) in MS patients cooled with a 4°C 
garment wrapped around the left and right thigh, while resting in a 23°C room. While skin 
temperature measured underneath the cooling garment undoubtedly decreased during cooling, 
both tympanic membrane and skin temperature measured outside of the cooling garment did not 
decrease following 1 h of cooling. These findings further highlight that a) improvements in 
fatigue and nominated symptoms seem to occur in the absence of any notable physiological 
changes, and b) the clinical significance of these findings is questionable given that it took a 
minimum of 1 h of cooling to elicit a ~4 second decrease in a 25 ft. walk test. Conversely, 
Gossman [42] reported no change in cognitive fatigue and cognition in MS patients cooled via a 
13°C water perfused vest resting in a 23°C room. The authors from this study hypothesised that 
no improvements in fatigue were observed due to the specificity of the fatigue (cognitive fatigue 
only as opposed to physical) that was being study.  
Within this literature, it has become evident that in the absence of a rise in Tcore and Tsk, 
MS symptoms and associated fatigue may transiently improve with the application of a cooling 
strategy, although the mechanisms that explain this improvement seem to be unclear. 
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Traditionally, the onset of heat-related symptoms and associated fatigue arise during exercise or 
when exposed to hot environments, however, few studies have investigated the efficacy of 
cooling strategies with heat exposure or during exercise to prevent the onset of symptoms for 
people with MS. As such, it is evident that further research is needed to establish evidence based 
practical and economical cooling strategies that can be used by people with MS.  
Globally, MS organisations and researchers [158] suggest MS patients keep cool by 1) 
staying hydrated [159-161], 2) wearing cooling vests [159,162,161], 3) using air-conditioning 
[159,162,161,160], pre-cooling (before exercise) [163] or staying indoors  [163,161]. However, 
evidence to support the efficacy of these cooling interventions is dubious and it is unknown 
whether cooling strategies such as wearing an ice vest or staying hydrated mitigate the onset of 
symptoms that heat-sensitive MS patients experience during exercise or when exposed to warm 
environments.  
A popular strategy used to alleviate the compounding effects of heat-related fatigue in 
healthy populations, particularly during exercise, is the ingestion of cold fluid. Indeed, Lee et al 
[164] demonstrated a ~23% increase in time to exhaustion with cold fluid (4°C) ingestion prior 
to and during a bout of cycling in a hot (35°C) environment. Furthermore, Mündel et al [165] 
and Trong et al [166] also demonstrated an increase in exercise capacity with cold fluid ingestion 
compared to warm fluid ingestion during a bout of exercise in the heat. The efficacy of cold fluid 
ingestion on exercise tolerance has not been investigated for people with MS. As such, Chapter 5 
of this thesis will investigate the influence of cold fluid ingestion of exercise capacity in heat-
sensitive MS individuals exercising in a hot environment.  
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2.5 CONCLUSION 
The history of literature investigating heat intolerance of people with MS extends beyond 
the scope of this thesis. While it is evident that being intolerant to the heat is problematic for 
people with MS, the underlying mechanisms responsible are still not well understood. From an 
autonomic thermoregulatory control perspective, there is a need to understand whether a) people 
with MS demonstrate elevated metabolic rates and core temperature at rest in thermoneutral 
environments and b) whether autonomic impairments are large enough to result in meaningfully 
greater rises in core temperature to the extent that thermoregulatory impairments may be at least 
partly responsible for heat intolerance in MS patients during exercise in hot environments. It is 
also evident that there is a need to identify practical and economical cooling strategies that can 
be used at home and/or work that can assist in symptom management, but more importantly 
investigate the efficacy of cooling strategies to improve exercise tolerance of people with MS in 
the heat. 
The overall purpose of this thesis was to a) investigate thermoregulatory responses in 
heat sensitive people with MS at rest (study 1) and during exercise (study 2) in a thermoneutral 
and hot environment and b) identify a practical and simple cooling strategy to improve exercise 
tolerance for heat sensitive individuals during exercise in the heat (study 3). Specifically, this 
thesis sought to determine whether resting core temperature and metabolic is elevated in people 
with MS, compared to healthy controls in temperate and hot environments. Furthermore, to 
assess whether an elevated core temperature at rest is associated with greater levels of 
subjective fatigue thereby placing people with MS at an inherent disadvantage during exercise 
or exposure to hot environments. Secondly, mechanistically investigate whether autonomic 
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thermoregulatory responses such as sweating, and vasodilation are independently impaired in 
people with relapsing-remitting MS while cycling in a hot environment. Finally, this thesis will 
investigate the efficacy of cold fluid ingestion on exercise tolerance for people with MS while 
cycling in hot environments.   
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Abstract 
Purpose: To reassess the notion that people with multiple sclerosis (MS) do not 
demonstrate an elevated resting core temperature when measured using best-practice precision 
thermometry.   
Method: Across two international data collection sites (Sydney and Dallas), twenty-eight 
relapsing-remitting MS patients and 27 aged-matched controls (CON) were exposed to either 
30°C, 30% relative humidity (RH) (Sydney) or 25°C, 30%RH (Dallas) environments. Resting 
rectal (Tre) and esophageal (Teso) temperature and resting metabolic rate was measured in MS 
(n=28) and CON (n=27) groups who completed the 25°C and 30°C trials. Tympanic membrane 
(Ttym) temperature was measured in MS (n=16) and CON (n=15) groups in the 30°C condition. 
A modified fatigue impact scale (MFIS) questionnaire was used to assess psychosocial, physical 
and cognitive fatigue in the 30°C condition.  
Results: Irrespective of ambient temperature, no group differences were observed for Tre 
(MS: 37.07±0.30°C; CON: 37.18±0.30°C; P=0.29), Teso (MS: 36.84±0.42°C; CON: 
36.92±0.29°C; P=0.36) or resting VO2 (MS: 3.89±0.18 ml·kg
-1·min-1; CON: 3.98±0.17 ml·kg-
1·min-1; P=0.67). Similarly, no group differences were observed for Ttym (MS: 36.52±0.38°C; 
CON: 36.61±0.33°C; P=0.55) in the 30°C condition. Resting Tre did not correlate with subjective 
measures of fatigue: physical: r= -0.11, P=0.67; cognitive: r= -0.14, P=0.60; and psychosocial: 
r=0.05, P=0.84. 
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Conclusion: Contrary to recent reports, resting core temperature and metabolic rate is not 
elevated in relapsing-remitting MS patients compared to healthy controls when measured using 
precision thermometry. Furthermore, no association was observed between resting Tre and any 
subjective measures of fatigue in a subset of participants with MS. 
Keywords: Body temperature, Uhthoff’s phenomenon, Fatigue, Heat sensitivity  
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Introduction 
It is well established that people with multiple sclerosis (MS) experience Uhthoff’s 
phenomenon, which is characterised by a transient worsening of symptoms with physical activity 
and/or exposure to hot environments [1]. Symptom severity is often different for each individual 
but in most instances, is accompanied by a rapid onset of fatigue [2]. While heat-related fatigue 
affects up to 90% of people living with MS [2], the underlying physiological mechanism is not 
well understood [3].   
Seminal work by Davis [4] established a potential link between a relatively small rise in 
core body temperature (~0.2 to 0.5°C) and the concomitant onset of heat-related fatigue in 
people with MS. Nonetheless, two recent studies [5,6] reported that people with relapsing-
remitting but not secondary-progressive demonstrate a slightly higher resting core temperature 
(~37.0°C) compared to healthy control subjects (~36.8°C), and that this higher resting core 
temperature was associated with greater subjective measures of fatigue. In both of these studies 
[5,6], core temperature was measured in the auditory canal via infrared thermometry using a 
standard off-the-shelf measurement unit, and in an uncontrolled environment. Yet, it is well 
established in the thermal physiological literature that core temperature measurements using this 
device do not agree well with more reliable measurements of core temperature assessed with 
precision thermistors placed in the esophagus or rectum [7-11]. When measuring core 
temperature using infrared ear thermometry, the 95% limits of agreement exceed those limits 
deemed acceptable (±0.3°C) for clinical practice [12,13]. Indeed, compared to pulmonary artery 
temperature (+0.45°C [95% CIs: -0.29 to +1.13°C]) and rectal temperature (+0.07°C [95% CIs: -
0.66 to +0.79°C)] infrared ear thermometry performs poorly [9]. Infrared ear thermometry even 
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fails to detect fever as defined by rectal temperature in four out of ten adults [11,14]. 
Notwithstanding these methodological concerns, from a physiological perspective it is 
challengeable that 1) a resting core temperature of ~37.0°C, which lays comfortably within the 
normal resting limits of internal body temperature [15], can be considered “elevated”; and 2) that 
a difference in resting core temperature of <0.2°C between population groups could be 
considered physiologically significant to the extent that it may be sufficient to induce fatigue in 
MS patients. The latter point is especially so given that core temperature can change by up to 
1.0˚C over a 24-h sleep-wake cycle [16]. 
The physiological mechanisms explaining any potential elevated core temperature in MS 
patients are not clear. Elevated resting core temperature in only relapsing-remitting MS patients 
have also been attributed [5,6] to a greater prevalence of systemic inflammation during this stage 
of the disease compared to those patients with secondary and primary-progressive MS [17]. It 
has been argued [5,6] that the core temperature set point in MS patients is elevated due to 
systemic inflammation in the central nervous system, akin to inflammatory induced fever [18] in 
healthy populations. However, it is well documented that fever is an acute inflammatory 
response to cell injury in the brain [19] and is associated with clinical manifestations such as an 
increased basal metabolic rate and cutaneous vasoconstriction [20,21]. To the best of our 
knowledge, there have been no reports of resting vasomotor dysfunction [22] or abnormal basal 
metabolic rates [23] in association with a core temperature of ~37.0°C in MS patients. 
Taken together, the aims of the current study were to test the following hypotheses: a) 
people with relapsing-remitting MS do not demonstrate an elevated resting core temperature 
when measured using precision thermistors placed in the esophagus, rectum and tympanic 
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membrane in a controlled, temperate (25C, 30%RH) and warm (30°C, 30% RH) environment 
compared to age and mass-matched healthy controls; b) people with relapsing-remitting MS do 
not demonstrate a higher resting metabolic rate compared to age and mass-matched healthy 
controls; and c) there is no association between resting core temperature and subjective measures 
of fatigue in people with relapsing-remitting MS. 
Methods 
Approval for this study was attained from the Human Research Ethics Committees at the 
University of Sydney (AUS) and Southern Methodist University (USA). All participants 
provided informed consent prior to their involvement in the study. A total of 28 relapsing-
remitting MS (MS) patients and 27 age- and mass-matched controls (CON) were recruited for 
this study. Sixteen MS and 15 CON participants completed trials in a climate-controlled chamber 
regulated at 30°C, 30% relative humidity (RH) at the Thermal Ergonomics Laboratory, 
University of Sydney, New South Wales; while 12 MS and 12 CON subjects completed their 
trial in a climate-controlled chamber regulated at 25°C, 30% RH at the Integrative Physiology 
Laboratory, Southern Methodist University, Dallas, TX. To ensure the no influence of the 
ambient environment on resting core temperature, two different environmental temperatures 
were tested. These ambient temperatures were chosen as they define the ‘thermoneutral zone’, 
where body temperature regulation at rest will occur in the absence of sweating [24].The study 
protocol was standardised between laboratories and all measurement tools used were identical. 
All testing was performed between 8:00 am and 1:00 pm to avoid potential effects of circadian 
rhythm. All participants avoided the consumption of alcohol and caffeine ~12 h prior and did not 
partake in any exercise ~24 h prior to participating in the study. All participants were non-
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smokers and free of any cardiovascular and/or metabolic diseases. Prior to any measurements 
being recorded, participants were asked to sit quietly for 30 minutes in the climatic chamber to 
ensure a steady-state core temperature was reached. Following this, data was recorded for 15 
minutes and the last minute of rest was used for data analysis. Core temperature values were 
deemed stable when they did not change by ±0.05°C within a five minute period. Participant 
characteristics are detailed in Table 3.1.   
Instrumentation 
Thermometry: Rectal (Tre), esophageal (Teso), and tympanic membrane (Ttym) temperature 
was measured using general-purpose paediatric thermistors (TM400, Covidien, Mansfield, 
Massachusetts, USA). For measures of Tre the thermistor was self-inserted to a depth of ~15 cm 
past the anal sphincter [25].  For measures of Teso, the thermistor was inserted to a depth of 40 
cm through the left or right nostril, estimated to be at the level of the area bound by the left 
ventricle [26]. Tre and Teso measurements were performed in both the 25°C, 30% RH (USA) and 
30°C, 30% RH conditions (AUS). Ttym was only measured in the 30°C, 30% RH condition 
(AUS). For measures of Ttym, the thermistor was covered with a cotton tip, placed in the aural 
canal until resting near the tympanic membrane and then insulated with cotton wool and ear 
defenders [27]. Ttym was deemed acceptable if the temperature was greater than ~36.4°C and/or 
within 0.2°C of Teso [27].  All temperature measurement methods employed follow standard 
procedures acknowledged internationally as best practice in the field of thermal physiology 
[28,25,27,29]. 
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Resting metabolic rate: Breath-by-breath resting oxygen consumption was measured via a 
metabolic cart (Quark CPET, Cosmed, Asia Pacific PTY, Sydney, Australia) [28,30] . Resting 
metabolic rate (RMR) was calculated using the following equation [28]: 
RMR = VO2·((
𝑅𝐸𝑅−0.7
0.3
) · 𝐸𝑐) + ((
1−𝑅𝐸𝑅
0.3
) · 𝐸𝑓) [kJ·min-1] 
Where: VO2 is the rate of oxygen consumption (L·min
-1); RER is the respiratory 
exchange ratio; Ec and Ef are the energetic equivalents of carbohydrate (21.13 kJL-1 of O2) and 
fat (19.62 kJL-1 of O2), respectively. 
Fatigue Questionnaire 
The modified fatigue impact scale (MFIS) is a multidimensional scale consisting of 21 
questions that require an answer ranging from 0 (never) to 4 (almost always) [31]. The MFIS 
covers questions of trait fatigue that pertain to physical, cognitive and psychosocial domains. 
The total time required to complete this questionnaire was ~10 minutes. Fatigue scores were 
calculated separately for each domain; physical (out of 36), cognitive (out of 40) and 
psychosocial (out of 8) where a low score was indicative of marginal fatigue and a high score 
indicated extreme fatigue [31]. Participants who attended the 30°C trials only completed the 
MFIS. The MFIS questionnaire was completed on the day of a participants’ trial.    
Statistical analysis  
All data are expressed as the mean and SD (±). A two-way ANOVA employing a non-
repeated factor of condition (two levels: 25°C and 30°C) and a non-repeated factor of disease 
(two levels: MS and CON) was used to analyse measures of Tre, Teso, resting metabolic rate, RER 
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and oxygen consumption. Measures of Ttym were compared between MS and CON groups in the 
30°C condition only, using a two-tailed independent sample t-test employing an α of 0.05. The 
association between resting Tre and fatigue in the 30°C, 30% RH condition were assessed within 
each domain (physical, cognitive and physcosocial) using a Pearson Correlation Coefficient test. 
All statistical analyses were performed using GraphPad Prism (v7.0, LA Jolla, CA, USA). 
Results 
Participant characteristics 
Participant characteristics are presented in Table 3.1. All people with MS were diagnosed 
with relapsing-remitting MS with an EDSS of 2.9 ± 0.9 (range: 2 – 5) and a disease duration of 
11.2 ± 10.4 y (range: 2 – 37 y). Disease modifying treatments (DMT) used by MS participants in 
this study are as follows: Tysabri (natalizumab), n = 7; Copaxone (glatiramer acetate), n = 4; 
Avonex (interferon beta-1a), n = 4; Gilenya (fingolimod), n =1; Tecfidera (dimethyl fumarate), n 
= 3; Lemtrada (alemtuzumab), n = 1; Fampridine (fampyra), n = 1; no DMT reported, n = 7. All 
data was collected between the hours of 8:00am and 1:00pm and there was no difference in the 
time at which data was collected between the MS and CON participants (P = 0.52). 
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Table 3.1. Participant characteristics 
Group Sex Age (y) Weight (kg) Height (m) BSA (m2) 
30°C Trial 
RRMS (n=16) 
CON (n=15) 
P value 
 
7 M/9 F 
7 M/8 F 
 
47 ± 11 
43 ± 10 
0.26 
 
77.6 ± 14.0 
78.0 ± 17.0 
0.93 
 
1.7 ± 0.1 
1.7 ± 0.1 
0.91 
 
1.9 ± 0.2 
1.9 ± 0.2 
0.88 
 
25°C Trial 
RRMS (n=12) 
CON (n=12) 
P value 
 
3 M/9 F 
3 M/9 F 
 
39 ± 9 
36 ± 12 
0.47 
 
78.3 ± 14.2 
76.1 ± 15.6 
0.73 
 
1.8 ± 0.1 
1.7 ± 0.1 
0.74 
 
1.9 ± 0.2 
1.9 ± 0.3 
0.71 
Core temperature 
No differences were observed in resting Tre (MS: 37.07 ± 0.30°C, n = 28; CON: 37.18 ± 
0.30°C, n = 27; P = 0.29; Figure 3.1A) or resting Teso (MS: 36.84 ± 0.42°C, n = 19; CON: 36.92 
± 0.29°C, n = 18; P = 0.36; Figure 3.1B) between groups irrespective of ambient temperature 
(Trial  Disease interaction: P = 0.28 (Tre); P = 0.52 (Teso)). Moreover, no differences were 
observed for resting Ttym (MS: 36.52 ± 0.38°C, n = 15; CON: 36.61 ± 0.33°C, n = 15; P = 0.55) 
between groups in the 30°C condition (Figure 3.1C). 
Metabolic rate 
Irrespective of ambient temperature, no differences were observed (P = 0.67) between the 
MS (3.89 ± 0.18 mL·kg-1·min-1; n = 27) and CON (3.97 ± 0.17 mL·kg-1·min-1; n = 23) for 
measures of resting oxygen consumption (Trial  Disease interaction: P = 0.77; Figure 3.2A) or 
metabolic rate in the CON (5.78 ± 0.18 kJ·min-1; n = 19) compared to the MS (5.33 ± 0.21 
kJ·min-1; n = 27; P = 0.12; Figure 2B) group, irrespective of ambient temperature (Trial  
Disease interaction: P = 0.88). Furthermore, RER (MS: 0.84 ± 0.02; n = 27; CON: 0.85 ± 0.2; P 
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= 0.70; n = 23; Trial  Disease interaction: P = 0.81 Figure 3.2C) was similar between groups. 
Fatigue 
Within the MS participants, no association was observed between resting Tre and scores 
of physical (r= -0.11, P = 0.67; Figure 3.3A), cognitive (r= -0.14, P = 0.60; Figure 3.3B), or 
psychosocial (r= 0.05, P = 0.84; Figure 3.3C) fatigue.
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Figure 3.1. Individual data and group means for measures of resting rectal (A), esophageal (B) and tympanic membrane (C) temperature. Values are provided for 
the relapsing-remitting (MS) MS (white diamonds) and control (grey diamonds). Data pooled from the 25°C and 30°C trials (Panel A-B). Tympanic membrane 
temperature was measured in the 30°C trial only (C) 
 
Figure 3.2. Individual data and group means for measures of resting oxygen consumption (A), and metabolic rate (B) in the 30°C and 25°C trials. Values are 
provided for the relapsing-remitting (MS) MS (white diamonds) and control (grey diamonds)
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Figure 3.3. Correlation between individual values of resting rectal temperature with measures of physical (A), 
cognitive (B) and psychosocial (C) fatigue. The dashed line represents the line of best fit 
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Discussion 
Using precision thermometry in the present study, no differences in esophageal, rectal or 
tympanic membrane temperature were observed between relapsing-remitting MS and healthy 
control participants during resting in a controlled environment of either 25°C or 30°C; an 
ambient temperature range that is within the standard boundaries of thermoneutrality at rest [1]. 
Furthermore, despite a higher resting metabolic rate in the CON group, no differences in resting 
oxygen consumption or RER were observed, nor was an association evident between resting 
rectal temperature and any subjective measures of fatigue (physical, cognitive, or psychosocial). 
These findings are contrary to recent research suggesting that resting core temperature, when 
measured in the auditory canal using infrared thermometry, is elevated (~0.2°C) in relapsing-
remitting MS patients compared to healthy controls. Furthermore, it has been proposed that this 
elevated core temperature is associated with higher levels of fatigue in people with relapsing-
remitting MS [2,3]. 
In almost all thermophysiological studies, the rectum or esophagus are preferred sites for 
measuring core temperature [4-8]. It is well documented that a temperature measured in the 
rectum is generally higher than temperature measured in the esophagus [9] - likely due to a lower 
rate of blood flow to the splanchnic area, which in turn decreases the amount of internal 
conductive/convective heat exchange of this tissue region [10]. Advantageously, a low thermal 
inertia in the rectum means that this measurement remains relatively stable under mildly varying 
environmental conditions at rest [10], and therefore arguably serves as the ideal measurement 
site to test the primary research question of the present study. Indeed, because of its validity and 
accuracy, rectal temperature is commonly measured in clinical [11,7] and athletic [12,4] settings 
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for diagnosing fever and heat stroke respectively. The lower esophagus is bound by the heart and 
pulmonary arteries, and because it has a relatively low heat capacity, esophageal temperature is 
finely regulated by the convective heat transfer from surrounding tissues [9,10].  The sensitivity 
of esophageal temperature to changes in central blood temperature and whole-body heat storage 
[5] are testament to the reliability of this measurement, specifically for detecting hypo- and 
hyper-thermia in intraoperative and postoperative adult patients [7,13,14]. The use of infrared ear 
thermometry may be useful in tracking acute changes in core temperature [4], however, few 
studies have successfully demonstrated the precision of this tool when measuring absolute core 
temperature [15,16,11,17-19]. A systematic review of 31 paediatric studies [15] demonstrated 
core temperature, when measured in the auditory canal with infrared thermometry, was severely 
under and/or overestimated (pooled mean: 0.29°C [95% CIs: -0.74 to 1.32°C]), as defined by 
rectal temperature when diagnosing fever (38.0°C as defined by rectal temperature). Similar 
findings were also reported by Stavem et al [16] when comparing infrared ear thermometry to 
pulmonary artery temperature for adults in intensive care (mean bias: 0.45°C [95% CIs: -0.29 to 
1.19°C]).  
The findings of the present study do not replicate those previously reported [2,3]. A direct 
measure of tympanic membrane temperature can be attained with a precision thermistor placed 
against the tympanic membrane, and when performed correctly, can potentially be a valid 
estimate of core temperature [20]. On the other hand, while infrared ear thermometry presents a 
relatively practical and quick method for measuring core temperature, and is commonly used in 
clinical settings, the accuracy of this method is heavily dependent upon the proximity of the 
sensor placement relative to the tympanic membrane which is affected by the curvature, length 
and circumference of the ear canal and the build-up of cerumen within the ear [19]. For this 
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reason, infrared ear thermometry often measures auditory canal surface temperature and not 
tympanic membrane temperature per se. Problematically, temperature measurements from the 
auditory canal can also be further influenced by ambient temperature and air flow [21-23].  
Furthermore, if a thermometer placed in the ear does not rest within close proximity to the 
tympanic membrane, skin temperature of the face and neck will also alter auditory canal 
temperature [20,24]. Previously reported [2,3] differences in resting core temperature may have 
been the result of placement of the infrared sensor in the ear canal alongside differences in 
environmental conditions (i.e. ambient temperature and wind speed). 
In the current study, external influences of the environment on resting core temperature 
were eliminated by tightly regulating ambient air temperature and humidity in a climate chamber 
(25°C, 30% RH or 30°C, 30% RH). Furthermore, all participants avoided physical activity ~24 h 
prior to testing, as per standard thermophysiological practice, to eliminate the possibility of 
elevated skin temperatures and body heat storage that could potentially contribute to elevated 
resting core temperatures upon arrival. Lastly, individual variability in resting core temperature 
can be dependent on the rate of heat transfer from the skin surface to the surrounding 
environment relative to body mass [25]. Although participant biophysical characteristics in 
previous studies [2,3] were not reported, it is possible that differences in body surface area-to-
mass ratio between groups could explain a difference in resting core temperature. In the current 
study, all participant groups were matched for physical characteristics (Table 3.1), thus 
eliminating the potential for differences in core temperature due to variability in relative heat 
transfer. 
It has been previously suggested that core temperature is higher in MS patients due to 
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systemic inflammation in the brain [2,3]. Despite a high prevalence of inflammatory attacks (a 
relapse) in MS patients, chronic and mild inflammation is also apparent in patients with 
secondary and primary-progressive MS [26,27]. Therefore, it seems unlikely that systemic 
inflammation would influence resting core temperature in MS patients only, and not all people 
diagnosed with MS. A recognised limitation of earlier studies [2,3] is that inflammation was not 
measured, thus making it difficult to confirm any link between inflammation and core 
temperature. Theoretically, an elevated core temperature by virtue of systemic inflammation 
would be accompanied by increases in metabolic rate. However, no difference in oxygen 
consumption and RER between MS and CON groups were observed in the present study. This 
observation is consistent with previous reports of similar resting metabolic rates and 
mitochondrial function of relapsing-remitting MS patients compared to healthy controls [28].  
Notably, resting metabolic rate was higher in the CON group compared to the MS group. 
However, it is evident that this slightly greater resting metabolic rate in the CON group has no 
influence on resting core temperature compared to the MS group.  
Finally, no association between subjective measures of physical, cognitive and 
psychosocial fatigue and resting core temperature was evident in the present study. These 
findings are also contrary with those in previous studies [2,3] where aural canal temperature was 
reported to be associated with elevated fatigue [3,2]. The MFIS is a subjective fatigue scale that 
relies heavily on individual experiences, interpretations and memory. Furthermore, the MFIS 
asks questions pertaining to fatigue over a four-week period and is not a direct indication of 
fatigue in the moment that core temperature is measured. As such, associating this subjective 
data with physiological measures may be problematic.  
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Limitations 
The present study does not include secondary-progressive MS patients. Previous reports 
suggest that relapsing-remitting MS patients demonstrate an elevated core temperature compared 
to patients with secondary-progressive MS due to a difference in systemic inflammation. As 
such, it is unclear whether a difference in resting core temperature would be observed when 
using the current methodology between relapsing-remitting and secondary-progressive MS 
groups. The sample size of this study was smaller than in previous studies [2,3], and tympanic 
membrane temperature was measured in an even smaller number of participants (MS: n = 15; 
CON: n = 15), as this was only possible in the 30°C trial. Furthermore, due to participant 
discomfort, esophageal temperature was not measured in all participants (19 of 28, and 18 of 27 
for the MS and CON group respectively). Nevertheless, according to Cohen’s d [29] the 
magnitude of differences for Teso (d = 0.22), Tre (d = 0.36), Ttym (d = 0.25) and resting metabolic 
rate (d = 0.29) further demonstrate a small difference between the MS and CON group means. 
Indeed, to observe a statistical difference in resting Teso, Tre and Ttym between MS and CON 
groups, a respective sample size of 884, 324 and 680 participants would be required.  However, 
based on the results of the current study, if such a mean difference was observed, it is likely that 
a) people with MS would have a lower resting core temperature compared to healthy controls, 
and b) this difference would be physiologically trivial. Therefore, we feel that additional 
participants would not change the conclusions of the present study. It is possible that resting core 
temperature may be influenced by DMT prescribed to people with MS. However, immediate 
prescription of DMT upon diagnosis is a part of the standard care procedures for people with MS 
[30] and does not seem to have any effect on resting core temperature for participants in the 
current study.  Lastly, it is possible that severe dehydration (a 1-2% loss of total body mass) can 
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increase resting core temperature by approximately 0.2°C. While we did not measure hydration 
status upon arrival, participants were instructed to consume approximately 500 mL of fluid prior 
to their trial to avoid the possibility of dehydration. 
Conclusion 
In MS and CON groups matched for age and mass, resting rectal, esophageal and 
tympanic membrane temperature measured using precision thermometry were not different in 
either a 25°C, 30% RH or 30°C, 30% RH controlled environment. Similarly, resting metabolic 
rate was similar between the MS and CON group and there was no evidence of any association 
between resting rectal temperature and measures of physical, cognitive and psycho-social 
fatigue. The current study illustrates the importance of employing precision thermometric 
methods in controlled environmental conditions when assessing differences in resting core 
temperature between clinical population groups.  
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Uhthoff’s phenomenon has previously been ascribed to people with relapsing-remitting 
MS who reached a critical absolute core temperature of ~37.0˚C. We reassessed this notion that 
an elevated resting core temperature would partially contribute to heat sensitivity for people with 
MS. Using precision thermometry, we demonstrated that indeed, absolute core temperature, at 
rest, does not attribute to Uhthoff’s phenomenon. Therefore, the next question that arose from 
this chapter was to determine if people with MS reach a critical absolute core temperature faster 
during exercise, due to thermoregulatory dysfunction, irrespective of core temperature at rest.  
From a thermal physiological perspective, the most apparent question would be whether 
people with MS demonstrate a blunted sweating response during exercise (in terms of how quick 
they start sweating and how they upregulate sweat output for a given rise in core temperature) 
due to autonomic dysfunction. If meaningful differences in sweating control were observed 
between and person with MS and a healthy control, then whole-body evaporative heat loss (the 
principal way humans dissipate heat from the body) would be lower, therefore resulting in a 
greater rise in core temperature, and thus potentially attributing to Uhthoff’s phenomenon. Thus, 
the aim of chapter 5 was to assess the independent influence of relapsing remitting MS on 
thermoregulatory (sweating) control during exercise in the heat. 
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CHAPTER V 
STUDY 2: THERMOREGULATORY 
RESPONSES OF MULTIPLE SCLEROSIS 
PATIENTS CYCLING IN WARM AND HOT 
ENVIRONMENTS 
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Thermoregulatory responses in multiple sclerosis patients cycling in warm and hot 
environments 
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Abstract 
Purpose: The impact of heat intolerance among people with multiple sclerosis (MS) is 
well documented. However, it is unclear whether this intolerance is due to an impaired 
thermoregulatory capacity, particularly during exercise. The aim of this study is to determine 
whether thermoregulation is independently altered in MS patients relative to healthy controls 
while cycling in a warm/hot environment. 
Methods: Fourteen relapsing-remitting MS participants (EDSS 2.7±0.8; 47±9 y; 
75.4±12.2 kg; 1.7±0.1 m) and 14 age- and mass-matched healthy controls (43±11 y; 78.6±17.0 
kg; 1.7±0.1 m) cycled at a fixed metabolic heat production of 4 Wkg-1 on a semi-recumbent 
ergometer for 40 minutes in a 30˚C, 30%RH environment. A subset of 8 relapsing-remitting MS 
(EDSS: 2.6±0.5; 44±8 y; 82.3±18.2 kg; 1.7±0.1 m) and 8 healthy controls (44±12 y; 81.2±21.1 
kg; 1.7±0.1 m) completed the same exercise intensity in a 35°C, 30%RH environment. Rectal 
(Tre) and mean skin (Tsk) temperature, upper back and forearm local sweat rate (LSR), and 
forearm cutaneous vascular conductance (CVC) were measured throughout.  
Results: Irrespective of ambient temperature, the change in Tre (MS: 0.38±0.18°C; CON: 
0.37±0.18°C; P=0.67) was similar between groups, but the change in Tsk was greater in the MS 
(1.50±0.72°C: P=0.02) compared to the CON group (1.00±0.67°C).  After 40 min of exercise, 
forearm LSR (P=0.059) but not back LSR (P=0.78) was lower in the MS group. The change in 
mean body (ΔTb) temperature (MS: 0.17±0.03°C; CON: 0.06±0.05°C; P=0.002) and onset time 
(MS: 15±2 min; CON: 7±1 min; P=0.002) was greater in the MS group for LSR at the forearm 
but not back (ΔTb: MS: 0.18±0.21°C; CON: 0.08±0.09°C; P=0.10; time at onset: MS: 13±2 min; 
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CON: 8±2 min; P= 0.12). CVC (P=0.50), SBF onset time (MS: 11±5 min; CON: 11±6 min; 
P=0.89) and ΔTb for SBF onset (MS: 0.09±0.09°C; CON: 0.12±0.11°C; P=0.57) was not 
different between the MS and CON group.  
Conclusion: Even during exercise at temperatures as high as 35˚C, the mild region-
specific sudomotor impairments in people with MS are not large enough to alter heat loss to the 
extent that greater rises in core temperature are observed. It therefore seems unlikely that 
intolerance to hot environments among people with MS can be attributed to thermoregulatory 
impairments. 
Keywords: Uhthoff’s Phenomenon, autonomic dysfunction, heat sensitivity, 
thermoregulation 
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Introduction 
Multiple sclerosis (MS) is an autoimmune, inflammatory demyelinating disease of  the 
central nervous system (CNS). Up to 80% of people with MS have an intolerance to the heat 
[1,2], also known as Uhthoff’s phenomenon [3], which describes a transient worsening of 
symptoms with exposure to a hot environment and/or during physical activity. In some patients, 
this heat intolerance subsequently reduces the capacity to work and perform household tasks [4], 
and increases the risk of falling [5]. Indeed, ~30% of people with MS will leave their job, with 
an additional ~40% admitting their job is at risk due to heat intolerance and associated symptoms 
[4].  
It is a widely held notion that an increase in core temperature from rest of 0.2 to 0.5°C 
will cause a transient worsening of MS symptoms due to a slowed or complete conduction block 
of temperature sensitive neurons [6,7]. A contributing factor to the rapid onset of heat intolerance 
may be a disproportionate rise in core temperature for a given metabolic heat load, by virtue of 
an impaired thermoregulatory response. A sufficient sweating and skin blood flow response is 
critical for regulating core body temperature during exercise and/or heat exposure. The onset of 
these effector responses and the rate at which sweat output and skin blood flow increases for a 
given rise in body temperature dictates the rate at which heat is stored within the body [8].  
 It has recently been reported that people with relapsing-remitting MS demonstrate a 
blunted sudomotor, but not vasomotor response when cycling at a fixed heat production in a 
neutral (25°C) environment [9]. Although this blunted sudomotor response was not large enough 
to alter the rise in core temperature compared to healthy controls [9], exercise in hotter 
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conditions that approach skin temperature (i.e. 30 to 35˚C) may elicit a net thermal load that 
exceeds the thermoregulatory capacity of people with MS sufficiently to cause much greater 
rises in body temperature for a given activity level. During uncompensable passive heating of 
MS patients with a 48°C water perfused suit, Allen at al [10] reported an average whole-body 
sweat rate that is 0.17 mgcm-2min-1 lower in people with MS relative to healthy control 
participants. If this difference in sweating is extended across the entire body surface, the parallel 
difference in evaporative potential should be sufficient to elicit up to a ~1.0°C greater rise in core 
temperature in MS participants after 40-min of exercise. Whether these observations translate 
directly to a hot non-encapsulated environment though, remains unknown. 
To assess any differences in time-dependent changes in core temperature and sweating 
between MS and healthy populations, any differences in body size must be accounted for in the 
experimental design. It has been recently demonstrated that prescribing exercise intensity to 
elicit a fixed metabolic heat production per unit total body mass (i.e. Wkg-1), irrespective of 
relative exercise intensity (i.e. percentage of maximum oxygen consumption; %VO2max) 
eliminates any systematic differences in the exercise-induced rise of core temperature due to 
biophysical factors [11,12]. Similarly, if participant groups are matched for body size, such an 
approach will also elicit a similar evaporative requirement for heat balance (Ereq) per unit surface 
area, which has been shown to determine steady-state local sweat rates, again irrespective of 
%VO2max [11].  
The overall aim of this study was to assess whether people with MS demonstrate 
impaired local sweat rate and skin blood flow responses to exercise in a warm (30°C, 30% RH) 
and hot (35°C, 30% RH) environment and whether these responses are sufficiently impaired to 
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elicit a greater rise in core temperature relative to age-matched control participants with a similar 
body size. We hypothesised that, compared to healthy control participants, people with MS 
would demonstrate larger rises in core and skin temperature secondary to a blunted sweat 
response, yet skin blood flow control would remain unaffected by MS.     
Methods 
Participants 
Fourteen relapsing-remitting MS patients with a disease duration of 11 ± 10 y, an 
expanded disability severity scale of 2.7±0.8 (1 = no disability, minimal symptoms; 5 = moderate 
disability, impairing daily activities) and 14 control participants (MS: 47±9 y; 75.4±12.2 kg; 
1.7±0.1 m; CON: 43±11 y; 78.6±17.0 kg; 1.7±0.1 m), matched for age and with a similar body 
size, were recruited to cycle in a warm (30°C, 30% RH) environment. A subset of 8 relapsing-
remitting MS participants (Disease duration: 8±8 y; EDSS: 2.6±0.5; 44±8 y; 82.3±18.2 kg; 
1.7±0.1 m) and 8 age and mass-matched control participants (44±12 y; 81.2±21.1 kg; 1.7±0.1 m) 
completed the same exercise bout in a 35°C, 30% RH room. These environmental conditions 
were chosen to represent the hottest temperature a heat-sensitive person with MS is likely to 
exercise in.  Eligible participants were free of any cardiovascular or metabolic disorders, and MS 
participants were excluded if they had experienced a relapse six months prior to commencing the 
study or were taking disease modifying treatment that included a muscarinic antagonist. All 
participants were informed of any risks involved with the study and provided their written 
informed consent. This study was approved by the University of Sydney Human Research Ethics 
Committee (HREC: 2015/125).  
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Study design 
All trials were performed in the Thermal Ergonomics Laboratory at the University of 
Sydney, Australia. All participants attended one preliminary trial and one experimental trial. 
During the experimental trials, participants cycled on a semi-recumbent ergometer at a fixed 
metabolic heat production (Hprod) of 4 W·Kg
-1 for 40 minutes. Participants completed their trials 
in either a 30°C, 30% RH (14 MS, 14 CON) or 35°C, 30% RH (8 MS, 8 CON) environment.  All 
participants abstained from alcohol and avoided strenuous exercise up to 24 h before their trial.  
Instrumentation 
Metabolic energy expenditure: Breath-by-breath metabolic rate (M) was calculated using 
indirect calorimetry via a metabolic cart (Quark CPET, Cosmed, Asia Pacific PTY, NSW, 
Australia). Minute-averaged values were calculated using the following equation [13]:  
                      M = VO2 · 
((
𝑅𝐸𝑅−0.7
0.3
).𝐸𝑐) + ((
1−𝑅𝐸𝑅
0.3
).𝐸𝑓)
60
 · 1000 [W]  
Where: VO2 is the rate of oxygen consumption (Lmin-1); RER is the respiratory 
exchange ratio; Ec and Ef are the energetic equivalents of carbohydrate (21.13 kJL-1 of O2) and 
fat (19.62 kJL-1 of O2) respectively. External workload was regulated using a semi-recumbent 
cycle ergometer (Corival Recumbent, Lode B.V., Groningen, Netherlands). The rate of heat 
production (Hprod) was calculated as the difference between M and external workload (W) and 
then converted into Wkg-1 by dividing by total body mass. 
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Core Temperature: Rectal (Tre) temperature was measured using general-purpose 
paediatric thermistor (TM400, Covidien, Massachusetts, USA). The thermistor was self-inserted 
to a depth of ~15 cm past the anal sphincter [14].   
Skin Temperature: was measured at four sites across the left side of the body using T-
type thermocouples (Concept Engineering, Connecticut, USA), secured to the skin using surgical 
tape. Mean skin temperature (Tsk) was expressed as a weighted average in accordance with 
Ramanathan [15]: chest 30%, shoulder 30%, thigh 20%, and calf 20%. All thermometric 
measurements were sampled every 5 seconds (NI cDAQ-91722 module, National Instruments, 
Texas, USA) and displayed in real-time using LabView (v7.0, National Instruments). Mean body 
temperature (Tb) was estimated using a weighting of 0.9 × Tre and 0.1 × Tsk [16,17]. 
Cutaneous Vascular Conductance: Skin blood flow (SBF) was measured using single 
fibre laser-Doppler flowmetry (Moor MS-LDF, Axminster, United Kingdom) with the sensor 
placed on the mid-forearm ~5 cm distal to the antecubital fossa. Cutaneous vascular conductance 
(CVC) was formulated every ten minutes during exercise using the minute-averaged laser 
Doppler flux units divided by mean arterial pressure (see Electrocardiograph and blood 
pressure) and expressed as a percentage of baseline values.  
Local sweat rates (LSR): were measured using 4.1-cm2 ventilated sweat capsules, secured 
to the skin using surgical tape (Transpore®, 3M, Ontario, Canada). Capsules were placed on the 
left upper back ~5 cm above the scapular spine over the trapezium and mid-forearm ~5 cm distal 
to the antecubital fossa. Anhydrous air was passed through each capsule at a constant flow rate 
of 750 mLmin-1 (Omega FMA-A2307, Omega Engineering, Connecticut, USA) and the 
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temperature and humidity of outflowing air were measured every 5 s using factory-calibrated 
capacitance hygrometers (HMT333, Vaisala, Vantaa, Finland). LSR measures were calculated as 
the product of change in absolute humidity across the capsule and flow rate and expressed 
relative to the area under the capsule in mgcm-2min-1. Steady state sweating is the local rate of 
sweating which is determined by the evaporative requirement for heat balance for a given body 
surface area.  
Absolute humidity was calculated using the following equation 
𝐴𝑏𝑠𝑜𝑙𝑢𝑡𝑒 ℎ𝑢𝑚𝑖𝑑𝑖𝑡𝑦 = 2.17 ∙  
𝑃𝑎
𝑇
  kg·m-3 
Where; Pa is the partial vapor pressure and T is the temperature in degrees Kelvin. 
Electrocardiograph and blood pressure: A wireless 6-lead ECG system recorded measures 
of heart rate (Quark ECG stress system, Cosmed, NSW, Australia). The same ECG system was 
used concurrently with an automated blood pressure monitor that was strapped to the 
participant’s arm throughout exercise (Tango M2, Suntech Medical, Inc. North Carolina, USA).  
Preliminary trial  
During the preliminary session, height and weight were recorded followed by a 
submaximal aerobic test on a semi-recumbent cycle ergometer. The submaximal test was used to 
determine the relationship between external work rate and oxygen consumption (VO2) and thus 
Hprod. The submaximal test protocol started with a 5-min warm-up period followed by 5-min of 
rest, after which the participant was fitted with a face mask attached to a metabolic cart. 
Participants began cycling at a resistance of 20 W below the predicted workload to elicit an 
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individualized Hprod of 4 Wkg-1, at a cadence of 60 rpm. The external workload of the bike was 
then increased by 20 W every three minutes for 4 separate stages or until volitional exhaustion 
[18].  
Experimental trials 
During the experimental trial, participants cycled on a semi-recumbent ergometer for 40 
minutes in a climate chamber regulated at 30°C, 30% RH (30°C) or 35°C, 30% RH (35°C). 
Participants were instrumented, weighed and baseline data was collected for 15 minutes, after 
which they began to cycle at a Hprod of 4 Wkg-1. At the cessation of exercise, ambient 
temperature was decreased to 20°C, 30% RH and participants were required to sit quietly for 30 
minutes while they cooled down and measures of BP and HR were recorded.  
Statistical Analysis 
All data are expressed as a mean with standard deviation (±). A three-way mixed 
ANOVA with a repeated factor of time (5 levels: 0, 10, 20, 30 and 40 min), and non-repeated 
factors of ambient temperature (2 levels: 30°C and 35°C) and disease (2 levels: MS and CON) 
was used to analyse time-dependent changes in Tre, Tsk, HR, LSR at the forearm and upper back, 
and %CVCbaseline of the forearm. A two-way ANOVA employing the non-repeated factors of 
ambient temperature and disease was used to assess differences in baseline Tre, ΔTb onset 
thresholds, time at response of onset, and thermosensitivity of LSR on the forearm and upper 
back and SBF on the forearm. Thermosensitivities for each participant were determined 
separately for LSR of the forearm and back, as well as SBF, using a simple linear regression for 
the period of linear increase until the start of a plateau in LSR and CVC plotted against the ΔTb. 
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The level of significance for all analyses employed an α of 0.05. If a significant interaction or 
main effect was observed, individual differences were assessed using an independent Student’s t-
test. All post hoc comparisons employed a Bonferoni correction. Statistical analyses were 
performed with SPSS (version 24, IBM SPSS, Chicago, IL, USA) and all data were graphed 
using GraphPad Prism (Version 7 La Jolla, CA, USA). 
Results  
No time-disease-trial interaction for observed for any of the independent variables, as 
such, all data from the 30°C and 35°C trial was pooled and are displayed independently of 
environmental conditions. 
Core and skin temperatures 
Absolute Tre was similar between MS and CON groups (P = 0.30) at rest, irrespective of 
ambient temperature (P = 0.59). The change in Tre was not different (P = 0.67) between the MS 
and CON groups (MS: 0.38 ± 0.18°C; CON: 0.37 ± 0.18°C) after 40 min of exercise (Figure 
5.1A) irrespective of ambient temperature (p = 0.56).  
After 40 minutes of exercise, the change in Tsk was greater (P = 0.02) in the MS (1.50 ± 
0.72°C) compared to the CON (1.00 ± 0.67°C) group (Figure 5.1B). However, this rise in Tsk for 
both the MS and CON groups was not influenced (P = 0.45) by ambient temperature (i.e. 30°C 
vs. 35°C). 
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Figure 5.1A and 5.1B. Mean change and error (standard deviation) in rectal (A) and skin temperature (B) for the 
MS (grey circles) and CON (black circles) groups. Values are pooled from the 30°C and 35°C trial for Tre (time-
disease-trial interaction: P = 0.59) and Tsk (time-disease-trial interaction: P = 0.45). Asterisk (*) denotes P < 0.05.  
 
Sweating 
Irrespective of ambient temperature (P = 0.87), local sweat rate of the upper back was not 
different (P = 0.46) between the MS and CON groups (Figure 5.2A). However, regardless of 
ambient temperature (P = 0.12) a time-disease interaction was observed for forearm LSR (P = 
0.01). Specifically, forearm LSR was lower in the MS group at the 20th (P = 0.02), 30th (P = 
0.04) but not the 40th (P = 0.06) min of exercise (Figure. 5.2B).  
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Figure 5.2A and 5.2B. Mean and error (standard deviation) for local sweat rate (LSR) of the upper back (A) and 
forearm (B) for the MS (grey circles) and CON (black circles). Values are pooled from the 30°C and 35°C trials for 
upper back (time-disease-trial interaction: P = 0.87) and forearm (time-disease-trial interaction: P = 0.12) LSR. 
Asterisk (*) denotes P < 0.05.   
The change in mean body temperature onset threshold for the forearm and upper back 
LSR and the subsequent thermosensitivity are displayed in Fig. 5. No disease-ambient 
temperature interaction was observed for the onset of LSR at the forearm (P = 0.72) or upper 
back (P = 0.74). However, the change in mean body temperature for the onset of forearm 
sweating was greater (P = 0.002) in the MS (0.17 ± 0.03°C) compared to the CON (0.06 ± 
0.05°C) group. No such difference was observed for upper back sweating (MS: P = 0.10). No 
disease-ambient temperature interaction was observed for forearm (P = 0.85) and upper back (P 
= 0.69) LSR onset time. On the other hand, the time at LSR onset (Figure 5.3C & D) was longer 
in the MS group for the forearm (P = 0.002) but similar between groups on the upper back (P = 
0.12). The LSR thermosensitivity was not different between groups for either the forearm (P = 
0.21) or the upper back (P = 0.69). The observed effects were the same irrespective of ambient 
temperature (forearm: P = 0.77; upper back P = 0.69).  
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Figure 5.3A-D. Change in mean body temperature plotted against the rise in upper back (A) and forearm (B) local 
sweat rate (LSR). Values are pooled from the 30°C and 35°C trials for upper back (disease-trial interaction: P = 
0.74) and forearm (disease-trial interaction: P = 0.72) LSR. Mean and error (standard deviation) for the time of LSR 
onset for the upper back (C) and forearm (D) between the MS and CON groups. Values are pooled from the 30°C 
and 35°C trials for upper back (disease-trial interaction: P = 0.69) and forearm (disease-trial interaction: P = 0.85) 
time at onset. Asterisk denotes P < 0.05.    
 
Skin blood flow measurements 
Irrespective of ambient temperature (P = 0.54), %CVCbaseline of the forearm was not 
different between the MS and CON (P = 0.50) groups (Figure 5.4A). The change in mean body 
temperature onset threshold for forearm skin blood flow (SBF) was similar (P = 0.57) in the MS 
(0.09 ± 0.09°C) compared to the CON (0.12 ± 0.11°C) group. Similarly, no differences were 
observed between the MS and CON group for the time at onset (Figure 5.4B) of forearm SBF 
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(MS: 11 ± 5 min; CON: 11 ± 6 min; P = 0.89) or the thermosensitivity (P = 0.49). These 
observed effects were the same irrespective of ambient temperature (ΔTb: P = 0.38; onset time: P 
= 0.87; thermosensitivity: P = 0.32).   
 
Figure 5.4A and 5.4B. Mean and error (standard deviation) values of cutaneous vascular conductance (CVC) of the 
forearm (A) following 40 min of exercise expressed as a percent of baseline and time at onset for skin blood flow 
(B) for the forearm. Values are pooled from the 30°C and 35°C trials for CVC (disease-trial interaction: P = 0.54) 
and time at onset of skin blood flow (disease-trial interaction: P = 0.87). 
 
Heart rate 
 Irrespective of ambient temperature (P = 0.69), there was no disease-heart rate interaction 
(P = 0.75). Furthermore, heart rate was not different at rest (MS: 75 ± 3 bpm; CON: 70 ± 2 bpm; 
P = 0.26) or after 40 minutes of cycling (MS: 105 ± 5; CON: 104 ± 4; P = 0.91) between the MS 
and CON groups.  
Discussion 
Our collaborative group has recently shown that compared to healthy controls, people 
with MS demonstrate a blunted sudomotor, but not vasomotor response during exercise at a fixed 
Thermoregulation in MS 
107 
 
 
metabolic Hprod (4.5 W·kg
-1) in a temperate climate (25°C, 30% RH) [9]. However, it was 
thought that due to the relatively cool conditions this blunted sweat response was not large 
enough to alter the rise in rectal and esophageal temperature following 60 minutes of exercise 
[9]. The findings of the present study extend our previous investigations to much hotter 
conditions (up to Ta=35°C). We found that when cycling at a fixed Hprod of 4 W·kg
-1 at these 
temperatures, the blunted sudomotor response in people with MS has regional specificity with 
decrements only observed on the forearm, but not the upper back. In parallel a greater rise in 
mean skin temperature was observed. However, similar rises in rectal temperature occurred 
between the MS and CON group throughout 40 minutes of exercise. Collectively, these data 
demonstrate that while a mild sudomotor impairment is present in people with MS, this is not 
sufficient to compromise heat loss during exercise to the extent that greater levels of deep body 
temperature occur with MS even at hot (up to 35°C) ambient temperatures.  
Sweat rates are predominantly determined by the amount of evaporation required to 
maintain heat balance [19], which by design was fixed between the MS and CON groups in the 
present study. Nevertheless, MS participants still demonstrated a lower sweat rate on the forearm 
(but not on the upper back) relative to healthy controls. Mechanistically, this lower localised 
sudomotor output seemed to be a result of a delayed onset relative to the change in mean body 
temperature in the MS group. A rise in deep and peripheral tissues temperatures during exercise 
in the heat activates local temperature-sensitive neurons that relay afferent information to the 
preoptic area of the anterior hypothalamus [20]. Neuronal firing rates are subsequently altered to 
elicit an efferent response such as an increase in sudomotor output. The present observation of a 
blunted forearm sweating response in the MS group indicates that pathophysiological events 
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within the CNS with MS may in some way impair this process. Indeed, it is known that injured 
neurons cause a reduction in conduction velocity and depress the efficiency of a postsynaptic 
response relative to a presynaptic stimulus [21-23]. Noronha [24] and Andersen [25] reported 
qualitative evidence of sudomotor impairments in MS patients during a bout of passive heating 
using the quinizarin powder test method. According to both studies [24,25] intravenous 
pilocarpine (a sympathetic cholinergic agonist) adequately increased whole body sweating rate in 
patients who previously demonstrated a blunted sweating response to passive heating. They 
postulated that a likely cause of sudomotor dysfunction for people with MS is the damage to 
neurons within the descending sudomotor pathway. Despite a blunted onset of the sudomotor 
response on the forearm in the present study, MS participants were still able to achieve the 
required steady-state sweat rate after ~40 minutes of exercise. As such, demyelination of neurons 
potentially only transiently weakens the temporal sudomotor response to exercise. 
Secondary to CNS impairments, it is also possible that insufficient stimulation of sweat 
glands due to physical inactivity [26] or avoiding exposure to hot environments may alter the 
central and peripheral adaptions to exercise in the heat [27-29]. Armstrong [23] suggested the 
neural adaptations to heat exposure, such as synaptic plasticity (in this instance, an increase in 
synapse strength), allow for adequate physiological control in hot environments. Accordingly, a 
decrease of synaptic plasticity may reflect irregular use of the thermoregulatory control system 
such as a delayed onset of sweating or a reduction in sweating rate [29,23]. Furthermore, Sato 
and Sato [27] demonstrated for physically active people, sweat glands had a higher cholinergic 
sensitivity, produced more sweat per unit volume of the gland, and were typically larger 
compared to self-reported sedentary people. Taken together, it is possible that heat-sensitive MS 
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patients demonstrate a blunted sudomotor response because of a) a reduction in the neuronal 
adaptations that occur with repeated heat exposure, b) a reduction in cholinergic sensitivity, c) a 
decrease in muscarinic cholinergic synapses and/or d) sweat gland atrophy, particularly if these 
patients avoid exercise and/or hot environments to prevent fatigue or a worsening of symptoms 
[30].  
It is widely acknowledged that local sweat rate can vary considerably across different 
regions of the body in healthy individuals [31-33], however it is unclear why sweating was 
blunted on the forearm only and not the upper back in people with MS. Region-specific 
differences in sweating rate have been observed in elderly (>64 y) compared to young men 
[32,34] during whole body passive heating. These previous studies reported a lower sweat gland 
output on the thigh and back in an elderly compared to a young population, while forehead, chest 
or forearm sweat gland output was similar between groups. It was hypothesised that these 
region-specific differences in sweating were the result of sweat gland atrophy and/or decreased 
cholinergic sensitivity [34]. Demyelination and scarring within the CNS is highly variable in 
terms of location and severity [24]. While we can only speculate, it is possible that a blunted 
sudomotor response on the forearm is due to a) demyelination specific regions within the CNS 
and/or b) local sweat gland atrophy. Nevertheless, irrespective of the underlying cause, the rise 
in core temperature was ultimately similar between MS and CON participants. Therefore, any 
differences in evaporative heat loss secondary to the lower sweat rates in the MS group on the 
forearm must have been minimal and/or compensated for greater sweating/evaporation at other 
body regions that were not measured, even at ambient temperatures up to 35°C.  
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There was a greater rise in Tsk in the MS group which may have been related to the 
greater evaporation in the CON group alongside lower local sweat rates, allowing for further 
cooling of the skin. However, it is evident that the benefit of any additional cooling was 
superficial and ultimately not great enough to alter the rise in core temperature. A greater rise in 
Tsk in the MS group may contribute to a warmer thermal perception (feeling hot) and perceived 
exertion during exercise. It is well known that sensations of warmth and an elevated perception 
of effort are predominantly driven by skin temperature particularly when a person starts exercise 
from a state of thermoneutrality/comfort [35-38]. Given one of the primary concerns for people 
with MS is heat-related fatigue, it is possible that higher mean skin temperatures contribute to 
elevated sensations of exertion, particularly during exercise.  
Lastly, skin blood flow control in people with MS was similar compared to healthy 
controls, as previously observed [10,39]. Cartlidge [39] reported an impaired sudomotor 
response in people with MS during passive heating in a water bath, despite no apparent 
impairment in vasomotor function. Similarly, Allen et al [10] reported differences in sweat 
output, but not cutaneous vascular conductance in MS compared to CON groups following a 
bout of whole body heating in a 48°C water perfused suit. It is therefore clear that pathways 
within the sympathetic nervous system exist that are impacted by MS are restricted to the 
sudomotor apparatus [40].  
Limitations 
It is unclear whether the blunted forearm sweat response in the MS group led lower 
whole body sweat losses as this was not measured in the present study. Nevertheless, the primary 
concern for people with MS during heat exposure is heat-related fatigue, which is presently 
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believed to be tied to the rise in core temperature [41]. It follows that irrespective of whether 
whole-body sweating was reduced in parallel with forearm LSR in the MS group or not, any MS-
related reductions in sudomotor output were apparently insufficient to alter core temperature. 
Due to technical limitations, we were unable to collect maximum skin blood flow values in the 
present study. While skin blood flow values are preferably reported as a percentage of a 
maximum response attained with local heat post-exercise, many studies present CVC values as a 
percent of baseline. However, the variability of baseline values was minimized by allowing for 
15 minutes of baseline data collection in a controlled environment [42]. Another possible 
limitation is the use of rectal instead of esophageal temperature to assess thermoeffector control. 
Obtaining esophageal temperature within this specific population proved difficult. Esophageal 
temperature measures were only obtained in 8 MS and 6 CON participants in the 30°C trials and 
in no MS or CON participants in the 35°C trials. As such, an insufficient number of esophageal 
temperature values were attained to conduct an appropriately powered thermoeffector analysis.  
Conclusion 
Despite a mild impairment of sweating on the forearm alongside slightly greater rises in 
mean skin temperature, deep core temperature in people with MS is not greater during exercise at 
a fixed heat production in a warm (30°C, 30% RH) or hot (35°C, 30% RH) environment. Future 
research does not need to focus on thermoeffector impairment during exercise for this population 
as any associated differences in skin surface evaporation seem to be minimal. 
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Collectively, chapters 3 and 5 demonstrated that while core temperature is not apparently 
influenced by MS, sudomotor control, to a mild extent, is. Nonetheless, this apparent impairment 
in sudomotor control is not sufficient enough to reduce whole-body evaporation to the extent that 
people with MS get hotter during exercise, even in air temperatures as high as 35˚C. The fact 
remains though that people with MS do experience a temporary worsening of their symptoms 
during exercise, albeit, MS organizations regularly recommend that people with MS use various 
cooling strategies to mitigate a temporary worsening of their symptoms. One strategy that is 
commonly recommended is the ingestion of cold water. Drinking cold water increases internal 
conductive heat loss and may reduce body core temperature during exercise in the heat. Cold 
fluid ingestion may also counteract mild reductions in skin surface evaporation due to 
the sweating impairments in people with MS as identified in chapter 5. Therefore, the aim of 
chapter 7 is to assess the influence of drinking cold water, which is readily available to most 
people, during exercise in the heat on exercise tolerance. Exercise tolerance in this case can be an 
indicator of MS-related heat sensitivity if compared to age and fitness-matched people without 
MS in the same environment. 
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CHAPTER VII 
STUDY 3: COLD WATER INGESTION IMPROVES 
EXERCISE TOLERANCE OF HEAT-SENSITIVE 
PEOPLE WITH MULTIPLE SCLEROSIS 
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Abstract 
Purpose: Heat intolerance commonly affects the exercise capacity of people with 
multiple sclerosis (MS) during bouts of hot weather. Cold-water ingestion is a simple 
cooling strategy but its efficacy for prolonging exercise capacity with MS remains 
undetermined. We sought to identify whether cold-water ingestion blunts exercise-induced 
rises in body temperature and improves exercise tolerance in heat-sensitive individuals with 
MS.  
Methods: On two separate occasions, 20 participants (10 relapsing-remitting MS (EDSS: 
1- 5); 10 age-matched healthy controls (CON)) cycled at ~40% VO2max at 30°C, 30%RH 
until volitional exhaustion (or a maximum of 60 min). Every 15 minutes, participants 
ingested 3.2 mL·kg-1
 
of either 1.5°C (CLD) or 37°C (NEU) water. Rectal (Tre) temperature, 
mean skin (Tsk) temperature, and heart rate (HR) were measured throughout.  
Results: All 10 CON, but only 3 of 10 MS participants completed 60 minutes of exercise 
in NEU trial. The remaining 7 MS participants all cycled longer (P=0.006) in CLD (46.4±14.2 
min) compared to NEU (32.7±11.5 min), despite a similar absolute Tre (NEU: 37.32±0.34°C; 
CLD: 37.28±0.26°C; P=0.44), change in Tre (NEU: 0.38±0.21°C; CLD: 0.34±0.24°C), absolute 
Tsk (NEU: 34.48±0.47°C; CLD: 34.44±0.54°C; P=0.82) and HR (NEU: 114±20 beats·min
-1; 
CLD: 113±18 beats·min-1; P=0.38) for the same exercise volume.  
Conclusions: Cold-water ingestion enhanced exercise tolerance of MS participants in 
the heat by ~30% despite no differences in core and mean skin temperatures or heart rate. 
These findings support the use of a simple cooling strategy for mitigating heat intolerance with 
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MS and lend insight into the potential role of cold-afferent thermoreceptors that reside in 
the abdomen and oral cavity in the modulation of exercise tolerance with MS in the heat. 
 
Keywords: Uhthoff’s phenomenon, fatigue, physical activity, heat sensitivities. 
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Introduction 
It is well documented that during physical activity and/or exposure to hot 
environments individuals with multiple sclerosis (MS) can experience heat intolerance (1), 
which is typically characterized by a rapid onset of fatigue (2). Despite its prevalence, the 
underlying mechanisms responsible for this phenomenon (Uhthoff’s) remain somewhat 
inconclusive. Nevertheless, since the work by Davis (3) and Rasminsky (4) it has been 
generally considered that a rise in core temperature of ~0.5°C induces heat-related fatigue 
secondary to slowed or blocked conduction of demyelinated nerves. As such, people with MS 
are regularly advised to remain indoors during hot weather, and limit physical activity, which 
can substantially impact employability and/or quality of life (5). 
Some cooling strategies administered before and/or during heat exposure successfully 
mitigate the development of heat-related fatigue in people with MS (6). However, these 
methods, such as 30 minutes of lower body cold water immersion (7) or donning an ice vest 
(8) can prove impractical in the context of everyday life and incompatible with many jobs. 
Cold fluid ingestion during physical activity is a simple strategy that is presently 
recommended by, among others, the National MS Society (9) the MS Society (UK) (10) and 
MS Queensland (Australia). Indeed, drinking cold water could effectively mitigate elevations 
in core temperature and associated fatigue as it introduces an internal heat loss avenue (via 
conduction) in addition to evaporative and convective heat loss from the skin surface. 
Nevertheless, to the best of our knowledge, no study has yet assessed whether cold fluid 
ingestion during exercise in the heat can mitigate rises in core temperature and accompanying 
fatigue in people with MS. 
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The aim of this study was to examine the effect of ingesting cold (1.5°C) compared to 
thermoneutral (37°C) water on exercise tolerance at a fixed low relative intensity 
(~40%VO2max), and the elevation in core temperature of heat-sensitive relapsing-remitting MS 
participants in a warm (30°C) environment. It was hypothesized that with thermoneutral water 
ingestion, exercise time would be shorter for MS compared to age- and fitness-matched 
control participants. It was also hypothesized that compared to thermoneutral water ingestion 
exercise time of MS participants would be extended with cold water ingestion due to a blunted 
rise in core temperature. 
Methods 
Participants 
Twenty participants, 10 individuals with relapsing-remitting MS, an expanded disability 
status scale (EDSS) range of 2-4.5 (1 = No disability, slight dysfunction in one area, 4.5 = 
significant disability with some limitation of daily activities (11)) and 10 age, height and 
weight-matched healthy controls with a similar estimated aerobic fitness (Table 5.1) were 
recruited for this study based on a power calculation (Heinrich-Heine-Universität Düsseldorf, 
Germany) employing an α of 0.05, a 1-β of 0.95 and an effect size of 1.55 for the main 
outcome variable of exercise performance with cold fluid ingestion in the heat (12). All MS 
participants had a self-reported intolerance to the heat. All participants were informed of any 
risks associated with the study before providing written informed consent. The study was 
approved by the University of Sydney Human Research Ethics Committee (HREC No: 
2016/214). 
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Table 7.1. Participant demographics 
 
MS (n=10) CON (n=10) P 
Sex 4M/6F 5M/5F 
 
Age (y) 47±9.2 43.8±5.5 0.35 
Weight (kg) 82.5±15.7 76.1±15.7 0.41 
Height (cm) 1.7±0.1 1.7±0.1 0.64 
BSA (m2) 1.9±0.2 1.9±0.3 0.57 
VO2max (L•min-1) 2.4±1.4 2.9±0.9 0.27 
 
Measurements 
Rectal (Tre) temperature was measured using a general-purpose paediatric thermistor 
(TM400, Covidien, Mansfield, MA, USA) self-inserted to a depth of 12 cm past the anal 
sphincter. Skin temperature was measured at four sites on the right side using thermistors 
(Concept Engineering, Old Saybrook, CT, USA) attached with hypoallergenic tape 
(Blenderm, 3M, Sydney, NSW, Australia). Mean skin temperature (Tsk) was estimated using 
a weighted average in accordance to Ramanathan (13). All thermometric measurements were 
sampled at 5 seconds intervals (NI cDAQ-91722 module, National Instruments, Austin, TX, 
USA) and displayed in real-time using LabView (v7.0). 
Heart rate (HR) was measured using a wireless 6-lead ECG (Quark T12x Asia 
Pacific PTY, Sydney, NSW, Australia) monitoring system. Electromagnetic gel was applied to 4 
foam electrodes, which were then placed under the right and left clavicle, the right and left 6
th 
intercostal and then covered with tape. Prior to the placement of the electrodes, the skin 
surface was shaved and cleaned with alcohol to ensure minimal signal interference. 
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Protocol 
Each participant completed one preliminary trial and two experimental trials. During the 
preliminary trial, participants performed an incremental submaximal exercise protocol 
(beginning at 45 W increasing 20 W every three minutes for a total of four stages) on a semi-
recumbent cycle ergometer (Corival Recumbent, Lode BV, Groningen, Netherlands) in a 
20˚C room. Heart rate and oxygen consumption (Quark CPET, Cosmed, Asia Pacific PTY, 
Sydney, NSW, Australia) were measured during each 3-min stage. A least square regression 
equation was employed using sub-maximal heart rate and oxygen consumption at the end of 
each stage and extrapolated to the maximum age-predicted heart rate (220-age) (14) to 
determine VO2max using the YMCA protocol (15). Individualized workloads (40% of 
predicted VO2max) were calculated for the subsequent experimental trials. 
Participants completed two experimental trials separated by a minimum of 48 h in a 
climate-controlled chamber at 30˚C and 30% relative humidity until i) volitional exhaustion, 
or ii) a maximum of 60 minutes. Participants were required to complete both trials at the 
same time of day to avoid any disparity in resting core temperature due to circadian rhythm. 
If any participant presented with a resting Tre more than 0.2˚C away from their previous trial, the 
trial would not commence. Participants cycled on a semi- recumbent cycle ergometer at a fixed 
relative intensity (~40%VO2max) and consumed a 3.2 ml·kg
-1 
aliquot of water (in <1 minute) 
after the 15
th
, 30
th
 and 45
th
 minute of exercise. 
Participants consumed either thermoneutral (37˚C) water (NEU) or cold (1.5˚C) 
water (CLD) during each experimental trial. The presentation of trials was balanced 
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between participants. The temperature of the water ingested in the NEU trial was maintained 
using a hydrostatic controlled water bath (DA05A, Polyscience, Niles, IL, USA). The 
temperature of the water ingested in the CLD trial was maintained in a thermos filled with ice. 
Immediately prior to fluid ingestion, the temperature of the fluid was verified using a factory-
calibrated glass precision thermometer (Durac Plus, Blue Spirit, Cole-Parmer, Vernon Hills, IL, 
USA) with a certified range between –1°C and +100°C and with an accuracy of ±0.1°C, 
and the required mass of water was measured using a balance with a precision of 0.1 g 
(MS12001L, Mettler Toledo, Columbus, OH, USA). Breath-by-breath oxygen consumption 
was continuously monitored to ensure participants were exercising at the target rate of oxygen 
consumption associated with a fixed estimated relative intensity throughout both trials. 
Statistical Analysis 
A two-way mixed ANOVA employing the repeated factor of water temperature (CLD, 
NEU) and the non-repeated factor of group (MS, CON) was used to examine exercise time to 
exhaustion (with a maximum of 60 min). The Tre, Tsk and HR at the time of exhaustion in the 
shortest trial for each individual were also compared to the same time point in the other trial 
within the MS and CON groups using paired sample t-tests. A within-group analysis of the effect 
of water temperature was employed for these measures due to different exercise times between 
the CON and MS groups. Furthermore, within the CLD trial for the MS group, the Tre and Tsk 
values at the same time as the time of exhaustion in the NEU trial were compared to the values at 
end-exercise using a paired sample t-test. Finally, an independent samples t-test was used to 
examine HR between CON and MS participants at 30 minutes of exercise for both the NEU and 
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CLD trials. All statistical analyses employed an α of 0.05 and were performed using GraphPad 
Prism (v6.0, LA Jolla, CA, USA). 
Results 
Exercise time was shorter in the MS group compared to the CON group (P=0.002), 
however an interaction was observed between water temperature and group (P<0.001). 
Specifically, all 10 CON participants completed 60 minutes of exercise in both the NEU and 
CLD trials (Figure 7 .1). On the other hand, while only 3 of 10 participants in the MS group 
completed 60 minutes of exercise in the NEU trial, 5 of 10 MS participants completed 60 
minutes of exercise in the CLD trial, and all 7 MS participants who could not complete the NEU 
trial cycled longer (Figure 7.1) in the CLD trial (NEU: 32.7±11.5 min; CLD: 46.4±14.2 min; 
P=0.006). During rest in the NEU trial (MS: 70.1± 11.3; CON: 77.2±24.5 beats·min-1; P = 0.51) 
and CLD trial (MS: 74.3±9.5; CON: 72.9±11.1 beats·min-1; P = 0.78)  and following 30 
minutes of exercise, HR responses in the NEU trial (MS: 104±15 beats·min-1; CON: 96±10 
beats·min-1; P=0.22) and the CLD trial (MS: 103±17 beats·min-1; CON: 92±12 beats·min-1; 
P=0.17) were not different, despite being moderately higher for the MS group throughout 
exercise. 
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Figure 7.1. Individual data and group means (with SD) for exercise duration in the NEU (yellow) trial and CLD 
(black) trial for multiple sclerosis (MS: squares) and healthy controls (CON: circles). Values given for: Exercise 
time to exhaustion with a maximum of 60 min. Asterisk (*) indicates P<0.05 between the NEU and CLD trial for the 
MS group 
Absolute Tre at rest in the NEU (MS: 36.93±0.40˚C; CON: 36.89±0.31˚C; P = 0.82) and CLD 
(MS: 36.87±0.33˚C; CON: 36.92±0.32˚C; P = 0.94) were not different. In the MS group, at the 
time of exhaustion in the NEU trial, change in Tre (P=0.66; Figure 5 . 2A), absolute Tre 
(P=0.44; Figure 7 . 2C), Tsk (P=0.82; Figure 5 . 2E), and HR (NEU: 114±19 beats·min
-1; 
CLD: 113±17 beats·min-1; P=0.45) were not different after the same amount of exercise time 
elapsed in the CLD trial. All 7 MS participants who cycled for longer in the CLD trial did so 
despite Tre (P=0.001) and Tsk (P=0.03) rising to higher values above the end NEU values when 
they did stop exercise (∆Tre: 0.26±0.12°C vs. 0.40±0.23°C; ∆ Tsk: 1.27±0.72°C vs. 
1.47±0.79°C). In the CON group, end-exercise (i.e. after 60 min in all CON participants) 
change in Tre (P=0.05; Figure 7.2B), absolute Tre (P=0.25; Figure 7.2D), Tsk (P=0.33; Figure 
7.2F), and HR (NEU: 99±11 beats·min-1; CLD: 99±13; P=0.33) were not different between the 
NEU and CLD trial. 
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Figure 7.2A-F. Individual data and group mean (with SD) at the end of exercise in NEU (yellow) trial compared to 
the same time point in the CLD (black) trial for multiple sclerosis (MS: squares) and healthy controls (CON: 
circles). Values given for: change in rectal temperature from baseline (Panels A-B), absolute rectal temperature 
(Panel C-D), and absolute mean skin temperature (Panel E-F). Asterisk (*) indicates P<0.05.  
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Discussion 
This study is the first to report the efficacy of cold-water ingestion for improving 
exercise tolerance in the heat in people with MS. Importantly, all MS participants that 
could not complete 60-min of exercise with the ingestion of thermoneutral water (NEU trial) 
due to volitional exhaustion, cycled for longer with ingestion of cold water (CLD trial). 
However, this longer exercise time in the CLD trial in the MS group was observed despite no 
influence of a lower ingested water temperature on core and skin temperatures as well as heart 
rate. 
It is well documented that even small increases in body temperature are associated with 
a transient worsening of symptoms for individuals with MS (3, 4), otherwise known as 
Uhthoff’s phenomenon (16). The development of fatigue, manifested by sensations of 
tiredness, is a common characteristic associated with Uhthoff’s phenomenon and explains the 
shorter exercise time for 7 of the 10 MS participants who could not complete 60 minutes 
of exercise compared to CON group in the NEU trial. Although we attempted to match groups 
for aerobic fitness, it is evident that the MS group had an end-exercise HR that was ~15 
beats·min-1
 
higher compared to the CON group in both trials. As such it is likely that 
VO2max of the MS group was slightly overestimated and therefore this group worked at a 
slightly higher relative intensity than the 40%VO2max target intensity. Nevertheless, 60 
minutes of exercise at intensities as high as 60%VO2max are sustainable even for older 
individuals (>60 y) with heart failure in the same environmental conditions as the present 
study (17). Therefore, the large difference in exercise duration in the MS group compared to 
the CON group cannot be attributed to differences in aerobic fitness; rather, they can be 
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primarily ascribed to the well-documented effects of MS on exercise capacity in the heat (1). 
Furthermore, given that relative exercise intensity and HR were consistent within the MS 
group between the NEU and CLD trials (NEU: 114±19 beats·min-1; CLD: 113±17 beats·min-
1), the main finding that a longer exercise time occurs with cold-water ingestion remains 
independent of any potential differences in fitness. 
Within the MS group, the longer exercise time to exhaustion in the CLD trial 
occurred despite a similar Tre, Tsk, and HR at a comparable time point (i.e. same volume of 
exercise) than the time to exhaustion in the NEU trial for each individual. In other words, 
exercise tolerance in the heat was improved in the MS group with cold-water ingestion 
despite no independent influence of ingested water temperature on the development of 
thermal and cardiovascular strain with exercise time. Indeed, from the time point at which 
exercise exhaustion was reached in the NEU trial, Tre and Tsk in the CLD trial continued to rise 
to higher values by the time exercise stopped. It has been previously suggested that the 
underlying mechanism responsible for heat-related reduction in exercise performance in 
healthy athletes is potentially similar to heat sensitivity with MS, but with fatigue onset 
occurring alongside much smaller rises in body temperature with MS (18). It follows that heat-
related decrements in the aerobic performance of healthy athletes can potentially be attenuated 
via the stimulation of cold-afferent receptors located in the oral cavity (12) and on the skin 
surface (19), without necessarily lowering core temperature. The present findings potentially 
support the notion that research examining the mitigation of heat- related decrements in 
exercise performance in healthy athletes may, at least to an extent, be translatable to the 
management of Uhthoff’s phenomenon in the MS population. 
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Irrespective of participant group, for the same volume of exercise core and skin 
temperature were altered negligibly by ingested fluid temperature (Figure 5 . 2A, C and E), 
despite the greater internal heat loss via conduction with cold fluid ingestion. A recent 
series of studies (20-22) described fluid temperature-dependent alterations in sweating 
during exercise that are modulated, independently of core and skin temperatures, by visceral 
thermoreceptors located in the abdomen. Ultimately, the reduction in evaporative heat loss 
from the skin surface with cold fluid ingestion was found to counterbalance the greater 
internal heat loss, thereby yielding similar changes in whole body heat storage and thus similar 
changes in core temperature, irrespective of ingested fluid temperature (20). Although 
sweating rates are not reported in the present study, a similar fluid temperature- dependent 
modulation of skin surface evaporation could explain the similar levels of thermal strain 
between the NEU and CLD trials within both the MS and CON group. Another 
consideration is that the absolute amount of heat transfer generated by each 3.2 ml·kg-1
 
aliquot of 1.5°C water, even without any parallel alterations of skin surface evaporation, would 
only be ~35 kJ, which for an 82.5 kg individual with a mean body specific heat of 3.49 
kJ·kg-1·°C-1
 
would yield a reduction in mean body temperature of only ~0.1°C. 
Despite the profound impact of regular exercise on the physical and psychological 
health of individuals with MS (23), it has been reported that people with MS are less 
physically active (24), partly to avoid a temporary worsening of symptoms associated with an 
elevation in body temperature. Moreover, heat intolerance has been shown to greatly impact 
the capacity for many people with MS to remain among the workforce (5). Cold water 
ingestion is a simple strategy for improving exercise tolerance in the heat, which could be 
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used as an alternative to other less practical but currently recommended cooling strategies such 
as partial immersion in cold water prior to heat exposure (7) or donning an ice vest (25). It 
should be noted though that for individuals with MS susceptible to urinary incontinence, 
additional fluid ingestion might not prove an optimal solution. Therefore, future research 
must establish whether independently stimulating cold-afferent thermoreceptors in the oral 
cavity, via a cold mouth rinse, would be sufficient to mitigate heat-related decrements in 
exercise tolerance with MS, as reported with complete cold-water ingestion in the present 
study. 
Limitations 
The present study does not include subjective measures such as whole-body thermal 
sensation (WBTS) or rate of perceived exertion (RPE). As such, it is unclear whether 
alterations in WBTS and/or RPE contributed to the longer exercise duration in the heat with 
cold-water ingestion. Similarly, the onset and severity of MS-related symptoms were not 
specifically assessed during or after exercise, and we therefore cannot rule out that the longer 
exercise duration, which was apparently promoted by cold-water ingestion, resulted in any 
prolonged symptom-worsening post exercise. Future research should therefore investigate 
whether prolonged exercise duration affects heat related MS symptoms, and if ingesting cold 
water mitigates the development of MS symptom severity during exercise in the heat. As some 
participants reported some mild discomfort during cold fluid ingestion future research should 
also assess the efficacy of ingesting slightly warmer fluid temperatures. 
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The exercise time to exhaustion protocol with a fixed end-point of 60 minutes was 
selected to assess the capacity of an easily fatigued, non-athletic population. However, due to 
the large variability that is typically demonstrated in time to exhaustion studies, future 
research should examine the reliability of a different study design to assess performance in MS 
individuals such as a fixed RPE (26) or a time trial protocol (27). Finally, VO2max values 
were estimated using HR and VO2 responses at submaximal workloads that were then 
extrapolated to an age-predicted maximum HR level. However, to the best of our knowledge 
this formula has not been validated in an MS population and therefore merits further 
investigation particularly given that VO2max seems to be slightly overestimated in the MS 
group in the present study. 
Conclusion 
In conclusion, the present study examined the influence of ingesting cold compared to 
thermoneutral water on exercise performance at a fixed low relative intensity 
(~40%VO2max), and the concurrent elevation in core and skin temperature of heat-sensitive 
relapsing-remitting MS participants in a warm (30°C) environment. With thermoneutral 
water ingestion, exercise time was shorter in the MS group compared to age-matched 
controls, presumably due to the development of fatigue associated with Uhthoff’s 
phenomenon. Cold-water ingestion resulted in a ~30% longer exercise time in the MS 
participants that could not complete 60 minutes of exercise in the thermoneutral water 
ingestion trial. However, while cold-water ingestion appeared to improve the exercise tolerance 
of the MS group in the heat, it did not blunt the rise in core and mean skin temperature 
with time. These findings provide a practical and simple strategy for individuals with MS 
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performing physical activity in hot environments and lend insight into the potential role of 
cold-afferent thermoreceptors that reside in the abdomen and oral cavity in the modulation of 
exercise tolerance with MS in the heat. 
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SUMMARY 
Multiple sclerosis is a demyelinating autoimmune disease of the central nervous system 
that results in scars and lesions in the brain and spinal cord. Symptoms most commonly 
experienced by people with MS include fatigue [1], cognitive decline [2], loss of balance [3], 
blurred vision, sensory enhancement (tingling or burning) and/or loss (numbness) [4], urinary 
incontinence [5] and sensitivities to the heat [6]. Up to 80% of people diagnosed with MS are 
sensitive to the heat, otherwise known as Uhthoff’s phenomenon, which is characterised by a 
temporary worsening of symptoms when exposed to hot environments and/or during exercise. 
Despite its prevalence the underlying physiological mechanisms that cause heat sensitivities 
remain unclear. Many researchers have alluded to the idea that a rise in core temperature as small 
as 0.2 to 0.5°C will cause a temporary worsening of symptoms. However, very little evidence 
exists to support or refute the notion that a small rise in body temperature will trigger an onset of 
symptoms. Many people diagnosed with MS also experience autonomic dysfunction. 
Specifically, sudomotor dysfunction has been reported in MS patients during bouts of passive 
[7,8] heating, however, to the best of our knowledge, no research has investigated whether a 
blunted sweating response during exercise in warm and hot environments reduces heat loss from 
the body to the extent that people with MS demonstrated a greater rise in core temperature 
compared to a non-MS population. Indeed, if this was the case then thermoregulatory 
dysfunction may, at least in part, contribute to the development of Uhthoff’s Phenomenon. 
It is widely held that physical activity provides psychological and physiological health 
benefits for people with MS. Problematically, many people avoid physical activity, especially 
during the summer months, to avoid a temporary worsening of symptoms and associated fatigue 
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[9,10]. To understand how core temperature influences Uhthoff’s phenomenon and how to 
mitigate the onset of symptoms at rest and during exercise, the capacity of autonomic 
thermoregulatory control in people with MS must first be determined at rest in both neutral and 
warm environments, and secondly during exercise in both warm and hot environments. 
Therefore, this thesis sought to 1) investigate whether resting core temperature is elevated in 
people with relapsing-remitting MS, compared to healthy controls and whether resting core 
temperature is associated with subjective fatigue levels, 2) determine whether people with 
relapsing-remitting MS demonstrate a greater rise in core temperature while cycling in a hot 
environment due to a blunted sweating response, and 3) after obtaining a clearer understanding 
of the thermoregulatory capacity in people with MS, we were able to determine a practical 
cooling strategy (cold fluid ingestion). As such, we assessed the effect of cold fluid ingestion on 
exercise capacity for people with MS compared to healthy controls while cycling in a hot 
environment. The primary findings of this thesis are as follows: 
1. Chapter 3 disproved the notion that resting core temperature is elevated in patients with 
relapsing-remitting MS. Indeed, this study demonstrated that using precision 
thermometry is imperative when assessing small differences in core temperature between 
groups and thus, resting rectal, esophageal and tympanic temperature are similar between 
MS and health control groups.  
2. Chapter 5 provided evidence that people with relapsing-remitting MS do not demonstrate 
greater rises in core temperature compared to healthy controls during exercise in the heat, 
despite a mild regional sudomotor dysfunction. 
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3. Chapter 7 demonstrated that, likely due to thermoreceptors within the mouth and upper 
gastrointestinal tract, ingestion of a cold (1.5°C) fluid during exercise in the heat can 
improve exercise capacity by ~30% by stimulating afferent receptors that provide 
information of cold sensations across the body. Importantly, this increase in exercise 
capacity occurred independently of changes in core and skin temperature. 
As these main findings were discussed within their respective chapters, the following 
sections pertain to the implications and future directions because of the findings from this thesis. 
IMPLICATIONS 
Autonomic thermoregulation in MS 
In chapter 3, the primary purpose of the investigation was to reassess the notion that 
rectal, esophageal and tympanic membrane temperature was elevated at rest in people with 
relapsing-remitting MS (RRMS) compared to healthy controls. Furthermore, the investigation 
sought to determine whether subjective measures of fatigue were associated with core 
temperature at rest. This study was designed based off previous research that demonstrated an 
elevated tympanic membrane temperature and associated fatigue in RRMS patients [11,12]. 
However, the physiological mechanisms that explained this elevated core temperature were 
unclear. When considering the human heat balance equation, a potential explanation for an 
elevated core temperature with MS may be a higher resting metabolic rate paralleled with 
vasomotor dysfunction, which can impair dry heat exchange at rest in normothermic conditions. 
However, why this would be limited to people with only RRMS and not secondary- or primary-
progressive MS as suggested in previous studies [11,12] is difficult to understand. Ultimately, 
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our findings highlight that metabolic rate alongside rectal, esophageal and tympanic membrane 
temperature at rest is not elevated in people with RRMS compared to healthy controls. 
Furthermore, core temperature is not associated with subjective measures of physical, 
psychosocial or cognitive fatigue in neutral (25°C, 30% RH) and warm (30°C, 30% RH) 
environments. Lastly, while measures of skin blood flow were not reported for this study, there is 
a body of research to support the notion that vasomotor control is not impaired in people with 
MS during heat stress [7,13,8,14-16] therefore it seems unlikely to be impaired at rest in 
thermoneutral conditions. 
In chapter 5, the purpose of the investigation was to elucidate whether a greater rise in 
core temperature during exercise in the heat, due to sudomotor impairments, was in part, 
responsible for heat intolerance in people with MS. Most research investigating sudomotor 
dysfunction in MS patients overlooked whether changes in core temperature were altered due to 
a blunted sweating response to passive heating. As such, it was unclear whether people with MS 
are sensitive to the heat during exercise due to a greater rise in core temperature, by virtue of a 
blunted sudomotor response. Findings from chapter 5 showed that although MS patients 
demonstrate a mild blunted sudomotor response on the forearm but not the upper back during 40 
minutes of cycling in a warm (30°C, 30% RH) and hot (35°C, 30% RH) environment; this 
blunted sweating response is not sufficient to compromise heat loss during exercise to the extent 
that greater levels deep body temperature occur with MS even at hot (35°C) ambient 
temperatures. Notably, the rise in skin temperature was greater in MS participants following 40 
minutes of exercise; however, this is likely due to a reduction in evaporation secondary to 
sudomotor dysfunction which was sufficient enough to impair superficial cooling (skin 
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temperature) however was not large enough to influence deep body temperature (rectal 
temperature). While it was hypothesised that MS patients would demonstrate a greater rise in 
core temperature compared to healthy controls, the findings from chapter 5 led to two major 
conclusions. Firstly, people with MS demonstrate sudomotor, but not vasomotor dysfunction, 
albeit, deep body temperature is not altered during exercise in warm and hot environments 
compared to healthy controls. This point is particularly important given in chapter 5, participants 
were cycling in ambient temperatures that are likely to represent the hottest conditions (30°C, 
30%RH and 35°C, 30% RH) a heat sensitive person with MS is likely to expose themselves to. 
Secondly, knowing that autonomic thermoregulation in not compromised in people with MS, 
future research should focus more intently on developing strategies to mitigate the onset of heat-
related symptoms and associated fatigue, and most notably, these strategies do not need to be 
developed to compensate for any major thermoregulatory dysfunction.  
Uhthoff’s Phenomenon and the role of core temperature 
While it is evident that exercise and/or exposure to hot environments will undoubtedly 
cause a temporary worsening of symptoms in MS patients, there is little evidence that supports a 
direct relationship between a rise in core temperature and the onset of heat-related symptoms and 
associated fatigue. Indeed, research by Nelson [17] in 1969 demonstrated that even in the 
absence of a rise in core temperature, sitting in a hot bath induced a transient worsening of 
symptoms in MS patients. Similar findings were observed by Guthrie [18] who noted after only 8 
minutes of whole body immersion in hot water MS patients presented with a worsening of 
symptoms. Furthermore, Poh et al [3] demonstrated a worsening of postural sway in MS 
individual exposed to hot environments, independently of changes in Tcore. Lastly, and what may 
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be most surprising, almost all research investigating Uhthoff’s phenomenon in MS patients, to 
the best of our knowledge, has only employed passive heating methods, and there was little to no 
replication of exercise induced symptom worsening for MS patients. This is of particular interest 
given Uhthoff’s first reports of symptom worsening was in patients following a bout of exercise 
(active heating)[6].  
 Fatigue, characterised as a ‘lack of energy and need for rest’ [19,1] is the most 
commonly reported heat-related symptom for people with MS  [1]. Because of the subjective 
nature of fatigue, there is currently no evidence that support the idea of a temperature threshold 
for the onset of heat-related fatigue. Indeed, Verikios [20] demonstrated that within Australia, 
30% of people diagnosed with MS living in Tasmania are likely to turn on their air-conditioning 
to keep cool when outside temperatures are 20°C compared to only 3% of those people living in 
South Australia. Conversely, 85% of people diagnosed with MS living in South Australia are 
likely to turn their air-conditioning on when outside temperatures reach 30°C compared to ~96% 
of those people living in NSW. Furthermore, Bol et al [21] demonstrated there was no 
correlation between subjective measures of physical and mental fatigue and ambient temperature 
for people diagnosed with MS living in the Netherlands. However, most studies investigating 
heat-related fatigue within the MS population [1,19,22] employ subjective questionnaires that 
rely heavily on individual experiences, interpretations and memory. Nonetheless, most data 
reported on heat-related fatigue seem to suggest that the onset and severity heat-related fatigue is 
subjective and dependent on an individual’s interpretation of how ‘hot’ they may feel. This raises 
questions as to whether a) core temperature actually influences heat-related fatigue for people 
with MS, b) whether heat induced fatigue occurs at lower rises in core temperature compared to 
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a healthy population [23] and c) whether there is a strong perceptual component to the onset of 
heat-related fatigue. Indeed, recent work by Filingeri et al [24] (Appendix D) demonstrated that a 
rise in rectal temperature as small as 0.4°C impairs cold peripheral thermal sensitivity compared 
to healthy controls. We hypothesised that small increases in core temperature impair afferent 
sensory signalling, potentially contributing to heat-related symptoms and fatigue in people with 
MS.  
In chapter 7, we demonstrate for the first time, that heat sensitive people with MS can 
mitigate heat-related decrements in exercise tolerance when ingesting cold water, independently 
of changes in core and skin temperature. This study highlights several important points: firstly, 
heat-sensitive MS patients can exercise for ~30% longer by ingesting a cold drink, without 
altering the rise in core temperature. This is likely due to cold-afferent thermoreceptors that 
reside in the abdomen and oral cavity [24]. Secondly, cold fluid ingestion provides a practical 
and economical strategy that MS patients can use during exercise to mitigate the onset of heat-
related fatigue. In doing so, improving exercise tolerance could allow MS patients to meet the 
weekly recommended physical activity requirements. Lastly, findings from this study suggest 
that there may be other physiological and perceptual mechanisms that influence heat-related 
fatigue for people with MS however future research is needed to investigate this notion. A final 
consideration for this study is that only 6 out of 10 participants were able to maintain exercise for 
40 minutes compared to all 14 participants being able to exercise for 40 in study 2 of this thesis. 
This is primarily due the difference in exercise intensity between the two studies. Indeed, in 
study 2, participants were working at a fixed relative heat production, therefore exercise intensity 
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would differ greatly between participants and between study 2 and study 3 where participants 
were working at a fixed % of their maximal oxygen capacity. 
FUTURE WORK 
The results from the present data give rise to further research questions, some of which 
are described below. 
In chapter 3, we established that resting core temperature was not elevated in people with 
MS, nor was it associated with elevated levels of fatigue. In chapter 5, we further highlight that 
during exercise in warm and hot environments, the rise in core temperature is similar between 
MS and control groups. Nonetheless, fatigue, specifically when exposed to hot environments is a 
big problem for most people diagnosed with MS. As such, future research should focus on 
identifying cooling strategies that could a) be used at home, work or during exercise to mitigate 
the onset of heat-related fatigue and symptom worsening and b) lessen the economic burden 
associated with symptom management. Future research should also consider the effect of heat 
intolerance for people with secondary- and primary-progressive MS. 
In chapter 7, ingesting cold-fluid during exercise in a warm environment was beneficial 
in improving exercise tolerance by up to ~30% independently of changes in core and skin 
temperature for heat intolerant people with MS. No perceptual measures, such as thermal 
sensation or rate of perceived exertion were measured during this study, and it is unknown 
whether exercise tolerance was improved due to perceptual differences due to the cold fluid 
ingestion. As such, there is a need to understand the relative physiological and psychological 
contributions to heat intolerance in people with MS. Future research should also investigate 
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whether prolonged exercise duration affects heat related MS symptoms, and if ingesting cold 
water mitigates the development of MS symptom severity during exercise in the heat. Lastly, 
given up to 83% of people diagnosed with MS [5] can experience urinary incontinence, future 
research could explore alternative cooling strategies that will stimulate cold afferent 
thermoreceptors to elicit a cooling effect, without having to ingest large amounts of fluid, such 
as a cold mouth swill.   
Limitations and delimitations 
Multiple sclerosis participants included in the experimental chapters of this thesis present 
with RRMS only, have an EDSS of four or below, and are considered otherwise healthy. Due to 
the novelty of the research within this thesis, the inclusion of a physically able (EDSS of 5 or 
below) and otherwise healthy MS population was important to ensure that any differences that 
were reported within the respective thesis chapters were the results of the disease itself. 
However, it is unclear whether the results of any studies included in this thesis would be 
different if people with secondary-and/or primary progressive MS, with a higher EDSS score, 
and perhaps presenting with co-morbidities would change the results of the studies included in 
this thesis. Furthermore, many people with MS are on disease modifying treatments (DMT) and 
it is unclear how some of these treatments may affect the results within the experimental 
chapters. Specifically, in chapter 5, participants were excluded if they were taking any 
muscarinic receptor antagonists to ensure that any blunted sudomotor response to exercise was 
because of MS and not due to their DMT. However, whether MS patients taking a muscarinic 
receptor antagonist medication are at a greater risk of thermoregulatory impairment remains 
unclear.  
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Thesis Conclusions 
The main findings from the experimental chapters in this thesis are as follows:  
1. Thermoregulation at rest is not impaired in people with relapsing-remitting multiple sclerosis 
in neutral (25°C. 30% RH) and warm (30°C, 30% RH) environments. Specifically, resting 
metabolic rate, alongside rectal, esophageal and tympanic membrane temperature is not 
elevated at rest in people with MS compared to healthy controls. Furthermore, subjective 
measures of physical, cognitive and psychosocial fatigue are not associated with resting 
rectal temperature in people with relapsing-remitting MS. The results from chapter 3 
highlight two important points 
a. When assessing differences in resting core temperature between clinical population 
groups, employing precision thermometric methods in controlled environmental 
conditions is imperative.  
b. People with MS are not at an inherent disadvantage in hot environments due to an 
elevated core temperature compared to healthy controls.  
2. Despite mild autonomic impairment of sweating alongside slightly greater rises in mean skin 
temperature, people with MS do not get hotter during exercise at a fixed relative heat 
production in a warm (30°C, 30% RH) and hot (35°C, 30% RH) environments. Future 
research could investigate whether the same autonomic impairment is observed in patients 
with a higher disease status and whether this has a meaningful physiological impact. 
3. Cold-water ingestion resulted in a ~30% longer exercise time to exhaustion in the MS 
participants that could not complete 60 minutes of exercise when ingesting room temperature 
water independently of rises in core and skin temperature. Furthermore, ingesting cold water 
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during exercise is a practical and economical strategy that can be employed to delay the onset 
of heat-related fatigue. These findings highlight that: 
a. A rise in core temperature may not independently contribute to heat intolerance for 
people with MS 
b. There may be other physiological and perceptual mechanisms that influence heat 
intolerance for people with MS.  
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